Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Hexavalent chromium at the crossroads of science, environment and public health

Yaroslav Zhigalenok, Aigerim Tazhibayeva, Saule Kokhmetova*, Alena Starodubtseva, Tatyana Kan, Dana Isbergenova and Fyodor Malchik
Al-Farabi Kazakh National University, Almaty, 050040, Kazakhstan. E-mail: tornatore@mail.ru

Received 2nd May 2025 , Accepted 13th June 2025

First published on 25th June 2025


Abstract

Hexavalent chromium (Cr(VI)) contamination represents one of the most persistent and complex environmental challenges of our time. This comprehensive review synthesizes current knowledge across toxicology, environmental geochemistry, analytical chemistry, and remediation technologies to reveal fundamental disconnects between scientific understanding and practical solutions. While research has elucidated molecular mechanisms of Cr(VI) toxicity with remarkable precision – from cellular entry through oxidative damage cascades to genomic instability – this knowledge has not translated into proportionally effective environmental remediation strategies. The analysis reveals that chromium contamination is more complex and persistent than traditionally acknowledged. The reversible nature of chromium redox transformations creates dynamic contamination cycles that resist conventional treatment approaches. Emerging evidence challenges the traditional safe Cr(III) versus toxic Cr(VI) paradigm, suggesting all chromium forms may pose health risks under certain conditions. Critical assessment of current remediation technologies demonstrates that while laboratory studies consistently report high removal efficiencies, these approaches fail to address the vast scale of existing environmental contamination. Most critically, conventional methods focus on transferring chromium between phases rather than implementing circular economy principles that enable recovery and reuse of this valuable element. The review concludes that to address the chromium crisis, it is necessary to move beyond conventional wastewater treatment and adopt prevention-focused strategies that emphasize circular economy principles. Future solutions must prioritize contamination prevention, closed-loop industrial systems, and long-term management rather than pursuit of complete remediation. Only through such realistic assessment and integrated action can we hope to minimize the ongoing impacts of this persistent environmental challenge.


1 Introduction

Industrial progress has relied on chemical compounds, many later found to pose serious environmental and health threats. Hexavalent chromium (Cr(VI)), a highly toxic and carcinogenic substance, is one such legacy, and its presence in ecosystems is now a global problem.1 The widespread use of chromium compounds in industries such as electroplating, leather tanning, pigment production, metallurgy, wood preservation, and many others2–4 has led to massive discharges of chromium-containing wastewater over decades. As a result, Cr(VI) is a common and dangerous pollutant in industrial effluents, soils, and alarmingly, in drinking water sources worldwide.5–7

Hexavalent chromium (Cr(VI)) is classified by the International Agency for Research on Cancer (IARC) as a Group 1 carcinogen, meaning a substance with proven ability to cause cancer in humans.8,9 In the United States, it consistently ranks among the top twenty most dangerous pollutants at monitored sites.8 Cr(VI) is highly mobile in water and easily penetrates cell membranes of living organisms.10,11 Once inside the cell, Cr(VI) initiates destructive processes: it causes powerful oxidative stress, directly damages DNA and proteins,12,13 disrupts cellular metabolism and energy production,14 causing many pathologies, including mutations, cell death, and cancer.13,15 Acute exposure to Cr(VI) can cause severe damage to internal organs – kidneys, liver, respiratory system,6 while chronic exposure is associated with increased risk of developing serious diseases.13,16

Cr(VI) enters the environment not only from industrial sources. Significant concentrations are also found in natural conditions, released during the weathering of chromium-containing rocks, especially under specific hydrogeochemical conditions.5,17,18 This natural origin complicates water quality control, especially in areas with relevant geology. Therefore, Cr(VI) contamination is a complex problem with serious consequences for public health and ecosystems.

In response to this threat, the global scientific community is making significant efforts to develop methods for removing Cr(VI) from wastewater and contaminated natural environments. The spectrum of proposed technologies is extremely broad and includes physicochemical approaches such as adsorption on various materials,19 ion exchange methods,20 membrane filtration,21 chemical reduction and precipitation,22 electrochemical methods,23 and photocatalysis,24 as well as biological methods using the ability of microorganisms25 and plants26 to absorb or transform. Parallel efforts have focused on developing advanced detection and monitoring systems, including portable colorimetric sensors,27 smartphone-based analytical devices,28 fluorescent probes,29 and real-time monitoring platforms30 that enable rapid field assessment of contamination levels. However, despite the diversity of approaches and the constant emergence of new developments, effective, economically viable, and environmentally safe solutions to the Cr(VI) problem on an industrial scale still remain an ongoing challenge.

The hexavalent chromium (Cr(VI)) problem has been the subject of numerous studies, reflected in an extensive body of scientific literature. A multitude of review articles focus on specific, albeit important, aspects, such as the mechanisms of its toxicity,10,31,32 its geochemistry,33 detection methods34,35 or specific cleanup technologies.8,36–39 The problem's complexity, stemming from the vast scale of environmental contamination, also demands a broader, interdisciplinary perspective. However, comprehensive reviews that bridge all fields are exceptionally rare. To our knowledge, at least one comparable study that covers sources, toxicity, and remediation together.40 While valuable, that review also maintains a specific focus on green bioremediation technologies, rather than providing a critical analysis of the practical barriers facing the full spectrum of cleanup methods.

This review provides a synthetic and critical perspective on the systemic nature of hexavalent chromium (Cr(VI)) contamination. It connects the fundamental mechanisms of Cr(VI) toxicity with its complex environmental behavior to substantiate public health risks. The review also presents an overview of modern detection methods, which are crucial for risk management. A key focus is the critical assessment of existing cleanup technologies from the standpoint of their practical effectiveness. By integrating findings from toxicology, geochemistry, analytical chemistry, and materials science, this work aims to foster a holistic understanding of the threat and identify promising directions for future interdisciplinary research.

This review is based on a systematic analysis of scientific literature from the Scopus, ScienceDirect, and Web of Science databases. The selection process prioritized peer-reviewed English-language publications and was conducted in two stages. Foundational works on chromium's fundamental toxicology and geochemistry, including seminal papers from the 1980s and 1990s, were included to provide essential context. The core analysis, however, is built upon current research from the last 5–7 years, focusing specifically on recent developments in detection, adsorption, and remediation technologies. All selected literature underwent a multi-stage screening, first by title and abstract, then by a full-text evaluation for available publications.

2 Biological damage of hexavalent chromium

Hexavalent chromium (Cr(VI)), found everywhere from industry and natural processes, is a toxicant causing deep concern in the global community due to its widespread presence in the environment and its proven detrimental effects on living organisms.41 Its danger contrasts sharply with Cr(III), whose biological role is still debated – formerly considered essential, but now with emerging data on its toxicity and ability to cause genomic instability under certain conditions.42 Unlike it, the hexavalent form of chromium is unequivocally recognized as a highly toxic substance, mutagen, and potent human carcinogen.43 The destructive action of Cr(VI) is not limited to carcinogenesis alone. The complex threat from acute or chronic exposure makes the Cr(VI) problem a priority for modern toxicology and public health. This chapter is devoted to the critical analysis of the biological damage inflicted by this element.

2.1. Clinical presentation of chromium intoxication in humans

Human exposure to hexavalent chromium (Cr(VI)) leads to a range of pathological conditions, which include severe effects from acute poisoning as well as chronic diseases, such as cancer.

Acute poisoning with high doses of hexavalent chromium (Cr(VI)), typically through the ingestion of concentrated solutions, causes severe and often irreversible damage. For instance, a documented case reported the death of an electroplating plant worker who accidently drank a production solution containing chromium.44 The clinical progression begins with initial symptoms like nausea and severe abdominal pain, followed by a rapid onset of multi-organ failure. The kidneys are a primary target organ in acute chromium ingestion, but the systemic toxicity extends to other vital systems, including the liver, gastrointestinal tract, and the cardiovascular and immune systems. Toxicological analysis in such cases confirms the rapid absorption and distribution of chromium throughout the body's tissues and organs.

While acute Cr(VI) poisoning is rare, chronic exposure to lower doses poses a more widespread and subtle threat, especially for workers in certain industries and populations living in environmentally compromised areas.41,45,46 The most ominous long-term consequence of chronic Cr(VI) exposure is the development of malignant neoplasms. Hexavalent chromium compounds are unequivocally recognized by IARC as carcinogens to humans, primarily based on the indisputable link with lung cancer found in workers engaged in chromate production, chromate pigments, electroplating, and stainless steel welding.47 Data on the association between oral or occupational Cr(VI) exposure and stomach cancer remain ambiguous: while one large meta-analysis found an increased risk,48 another did not confirm a statistically significant increase in the risk of stomach cancer or other GI tract cancers from occupational exposure,49 which may indicate the complexity of assessing this risk or dependence on the specifics of cohorts and exposure levels. Recent in vitro and in vivo studies demonstrate Cr(VI)'s ability to stimulate proliferation and invasion of prostate cancer cells, which, coupled with data on elevated chromium levels in serum of such patients, indicates its potential role in the progression of this disease, although this issue requires further detailed study.50 Beyond oncological diseases, long-term Cr(VI) exposure causes a wide spectrum of non-carcinogenic toxic effects affecting multiple organs and systems.

The respiratory system, being the main entry route for Cr(VI) during occupational exposure, suffers not only from the risk of cancer development. Chronic inhalation of Cr(VI) compounds leads to irritation of mucous membranes, chronic inflammatory diseases, development or exacerbation of bronchial asthma.41 Studies also show direct structural damage to lung tissue, including alterations at the alveolar level and disruption of mitochondrial function in epithelial cells,13,51 which inevitably reduces the efficiency of gas exchange between air and blood and may contribute to the development of chronic respiratory failure.

The skin, as the first barrier against toxicants during contact exposure, is also subject to its aggressive influence. This manifests as characteristic contact dermatitis, allergic reactions, and the formation of difficult-to-heal “chrome ulcers”.52 At the cellular level, Cr(VI) has been shown to disrupt the skin's barrier function by damaging intercellular junctions and inducing apoptosis of keratinocytes53 – that is, death of the main epidermal cells. The reduction in the number of these cells weakens the skin barrier: it thins, loses its integrity, which opens the way for infections and makes the skin more susceptible to further chemical damage.

The kidneys, as a vital organ of the excretory system, are particularly vulnerable to Cr(VI) exposure, especially in acute poisoning, but also with chronic accumulation. Nephrotoxicity develops, characterized by damage to the renal tubular epithelium, which can lead to impaired filtration and reabsorption function of the kidneys.54 As a result, the kidneys lose their ability to effectively cleanse the blood of metabolic waste and toxins, as well as maintain the necessary water-salt balance in the body. This damage often results in proteinuria, the leakage of proteins into the urine, which are normally retained in the blood during healthy kidney function.55 In severe cases, this progresses to chronic renal failure requiring dialysis or transplantation.

The liver, as the center of metabolism and detoxification, also serves as a target for Cr(VI). Hepatotoxic effects manifest in disruption of metabolic functions and degenerative changes in hepatocytes (the main working cells of the liver). With prolonged exposure, activation of hepatic stellate cells is described, triggering the development of liver fibrosis.56 Fibrosis is a pathological process of replacing normal, functional liver tissue with coarse connective (scar) tissue. As fibrosis progresses, the liver loses its functions, which can lead to the development of cirrhosis – a severe, irreversible condition.

Also of concern is the reproductive toxicity of Cr(VI), which threatens fertility and offspring health. In women, severe consequences such as follicular atresia57 – that is, premature degeneration and death of follicles containing eggs, which directly leads to depletion of the egg supply (ovarian reserve) and development of infertility – disruption of steroidogenesis and delayed puberty are described, with epigenetic changes in ovarian tissue possibly underlying these disorders.57 The male reproductive system is no less vulnerable: Cr(VI) causes testicular tissue damage, leads to decreased testosterone levels, disrupts lipid metabolism processes and autophagy in the testes,58 and also exhibits toxicity toward spermatogonial stem cells.59 These cells are the progenitors of all sperm and ensure their continuous production throughout a man's life, so their damage or death can lead to serious and prolonged, up to irreversible, impairment of male fertility. Reproductive dysfunction may also be related to the toxic effect of Cr(VI) on the pituitary gland, a regulator of the endocrine system.60

Finally, increasing evidence points to the neurotoxic potential of Cr(VI), although this area still requires active study. Animal model studies demonstrate behavioral, learning, and memory impairments with chronic Cr(VI) consumption in drinking water even at concentrations considered relatively safe.61 Review data suggest a possible link between Cr(VI) exposure and cognitive development disorders in children, deterioration of smell and social memory, and also suggest its potential contribution to the development of neurodegenerative processes and motor neuropathies in adults,31 which inevitably affects quality of life, learning ability, and social adaptation of those affected. The entire spectrum of described pathological effects of Cr(VI) on the main systems of the human body is summarized in Fig. 1.


image file: d5ra03104d-f1.tif
Fig. 1 Main clinical manifestations of possible consequences of toxic exposure to Cr(VI) on human organs and systems.

The diverse pathological effects of hexavalent chromium (Cr(VI)), such as lung cancer, kidney failure, infertility, and memory loss, share a common underlying mechanism: the destruction of specialized cells within various organ systems. Cr(VI) targets multiple cell types, including respiratory epithelium, liver hepatocytes, kidney nephrons, as well as skin, reproductive, and nerve cells. The death or dysfunction of these functional cells leads directly to the failure of their respective systems, such as respiration, detoxification, excretion, reproduction, and cognitive functions. Thus, the clinical presentation of Cr(VI) toxicity reflects a systemic failure at the cellular level.

2.2. Molecular mechanisms of Cr(VI) induced cell damage

The primary factor determining the toxicological activity of Cr(VI) is its ability to easily overcome the cellular barrier – the plasma membrane. In physiological conditions, Cr(VI) exists predominantly as a tetrahedral chromate anion (CrO42−), which in structure and charge resembles vital anions for the cell – phosphate (PO43−) and sulfate (SO42−). Due to this structural similarity, Cr(VI) effectively uses cellular transport systems and is actively transported into the cell by proteins that carry these anions, such as chloride intracellular channels (CLIC).62 This mechanism ensures rapid entry of the toxic compound into the cytoplasm. This represents a cardinal difference from trivalent chromium (Cr(III)), which exists as a cation and for which cell membranes are practically impermeable.63

Once inside the cytoplasm, Cr(VI) undergoes a multi-stage reduction to lower oxidation states: Cr(VI) → Cr(V) → Cr(IV), and finally to the relatively stable form, Cr(III).64,65 This process is essentially a toxic activation of chromium inside the cell. This reduction occurs through two main pathways. The first is a non-enzymatic process involving low molecular weight reducing agents like ascorbic acid (vitamin C)66 and glutathione (GSH).63,67,68 The second pathway utilizes enzymatic systems, such as cytochrome P450 reductase and glutathione reductase.65,68 The main toxicity of Cr(VI) is caused not by the final reduction product (Cr(III)), but by the process itself and the short-lived but extremely reactive intermediate forms – Cr(V) and Cr(IV) ions.64,65

The intracellular reduction of Cr(VI) inevitably triggers powerful oxidative stress, a state where the cell's ability to neutralize aggressive oxidants is overwhelmed. Unstable chromium ions (Cr(V), Cr(IV)) actively react with molecular oxygen, leading to the massive generation of reactive oxygen species. These damaging particles include the superoxide radical (O2), hydrogen peroxide (H2O2), and the extremely aggressive hydroxyl radical (OH˙).43,69,70 The cell's antioxidant defense systems, which normally handle ROS, are quickly overloaded. Key protective enzymes are depleted or suppressed, and the cell's primary non-enzymatic antioxidant, glutathione (GSH), is critically depleted.70–72 As a result, ROS can freely attack vital cellular components like lipids, which form the structure of all cellular membranes, disrupting their integrity and function.

The attack of ROS on lipids, which form the structural basis of cellular and intracellular membranes, leads to their oxidation (formation of lipid oxidation product – LOP) – a chain reaction of oxidation by free radicals, which disrupts the structure and fluidity of membranes, their barrier function and integrity.73 Damage to the membranes of mitochondria, lysosomes, and the plasma membrane itself opens the path to further cellular dysfunction and death.

One of the main targets of Cr(VI), which determines its mutagenic and carcinogenic potential, is the cell's genetic material – DNA. This damage to the genome, known as genotoxicity, is a multifactorial process resulting from both oxidative stress and the direct interaction of chromium ions with DNA.74,75 This assault on the genome leads to various types of damage, including Cr-DNA adducts (where chromium directly binds to DNA), DNA-protein crosslinks, and breaks in the DNA chains.12,76,77

If this damage is not properly repaired by the cell's systems, or if those systems are overloaded, the consequences for the genome are severe. These include point mutations (changes in the DNA sequence), large-scale chromosomal aberrations (such as breaks, deletions, and translocations of chromosome parts), and changes in the total number of chromosomes (a condition known as aneuploidy).74,78,79 All of this leads to a state of genomic instability – an increased frequency of genetic changes, which is a fundamental characteristic of cancer cells and a major driver of their development.80

However, the genotoxicity of Cr(VI) is not limited to direct DNA damage. There is growing evidence for the important role of epigenetic mechanisms – heritable changes in gene expression that are not caused by alterations in the DNA sequence itself. Cr(VI) has been shown to alter DNA methylation patterns, affect modifications of histones (the key proteins that package DNA),9,57 cause instability in ribosomal DNA (rDNA),15 and disrupt the expression of microRNAs (small regulatory molecules that control gene activity).81 Epigenetic marks normally function as a precise system for “switching” genes on and off at the right time. When Cr(VI) disrupts this system, genes that stimulate cell growth (proto-oncogenes) can become permanently “switched on”, while genes that should stop uncontrolled division or trigger DNA repair (tumor suppressor genes) can be erroneously “switched off”.

Cr(VI) not only damages DNA but also disables the cell's repair systems. A key repair pathway for severe DNA damage, known as homologous recombination, has been shown to be inhibited by prolonged Cr(VI) exposure.12,82 This creates a double-hit scenario: the cell sustains more genetic damage while its ability to fix it is compromised.

The accumulation of these molecular damages – oxidative chaos and genomic instability – inevitably leads to a profound dysfunction of cellular systems. Beyond DNA, another key target is the mitochondria, the cell's energy stations. Cr(VI) damages their membranes, disrupts their respiratory processes, and reduces the synthesis of ATP (the cell's main energy currency). As a result, the cell's metabolism shifts toward anaerobic glycolysis, a much less efficient way of producing energy.13,14,69

The impact of Cr(VI) also extends to the endoplasmic reticulum (ER), the cell's factory for producing and folding proteins. The accumulation of defective proteins inside the ER causes a condition known as ER stress. The cell responds with a special program called the unfolded protein response (UPR) to restore order or, if the damage is too severe, to trigger cell death. The effect of Cr(VI) on ER stress is dose-dependent: low concentrations induce moderate stress, while high concentrations can suppress the response.83 The transcription factor ATF4 plays a key role here, altering the cell's metabolism and promoting survival at low doses of Cr(VI), while its levels decrease at high doses.84

Cell cycle regulation is also thrown into disarray. In response to DNA damage, checkpoints may be activated (for example, in the G2/M phases) to stop cell division and allow time for repairs. However, with strong or prolonged exposure, these protective mechanisms can be overridden or damaged, contributing further to the accumulation of mutations and chromosomal instability.12 Additionally, Cr(VI) interferes with numerous intracellular signaling pathways that control critical processes. These include pathways regulating cell growth and differentiation, such as Hedgehog85 and EMT;50 pathways crucial for cell survival that manage stress and apoptosis, like Akt,69 ATR,66 and Nrf2;43 and those that control cellular metabolism, such as AMPK69 and HIF1α.86

Ultimately, when the level of damage exceeds the cell's ability to adapt and repair, mechanisms of cell death are triggered. Depending on the context, this may be apoptosis – active, programmed cellular death,53,60,72,86 necrosis – passive, uncontrolled cell disintegration,70,87 or other forms of regulated death, such as pyroptosis87 or death associated with autophagy/mitophagy.58,59 A visual summary of the molecular mechanisms of Cr(VI) toxicity considered is presented in Fig. 2.


image file: d5ra03104d-f2.tif
Fig. 2 Molecular mechanisms of Cr(VI) cellular toxicity.

The mass death of these functionally active cells – be they in the liver, kidneys, lungs, or reproductive system – is the direct cause of the organ-level damage described in Section 2.1. The loss of a significant part of the cell population leads to organ failure, chronic inflammation, and fibrosis. If, however, a cell manages to avoid death despite the accumulated genetic and epigenetic damage, it has a direct predisposition to uncontrolled division and malignant transformation, leading to the development of cancer.

Thus, the toxicity and carcinogenicity of hexavalent chromium are caused by a unique and destructive cascade of events. Its easy entry into the cell, its subsequent toxic activation, the induction of powerful oxidative stress, and the multi-pronged assault on the genetic apparatus (including DNA damage, epigenetic alterations, and suppression of repair) all lead to the disruption of key cellular functions or cell death. These events at the cellular level directly translate into the pathologies observed at the level of the whole organism – organ failure, systemic diseases, and cancer – which explains why Cr(VI) presents such a serious and complex biological hazard.

2.3. Controversial issues and uncertainties in chromium toxicology

Despite the extensive body of data on the clinical manifestations and molecular mechanisms of hexavalent chromium toxicity, attempts to provide an assessment of its actual risk to human health and ecosystems face a number of serious obstacles. Existing scientific contradictions, methodological difficulties, and significant knowledge gaps do not allow us to determine with complete certainty the true scale of the threat. Furthermore, data suggests current risk assessments may significantly underestimate the long-term effects of Cr(VI) exposure.

The traditional opposition of “bad” Cr(VI) and “good” Cr(III) is increasingly being challenged. Historically, Cr(III) was considered minimally toxic42,47,88 and an essential element (though its essentiality is disputed89), and its formation from Cr(VI) was seen as detoxification. However, data is accumulating on the significant biological activity of Cr(III) itself, especially when formed intracellularly or introduced as complexes (such as chromium picolinate42). It exhibits geno- and cytotoxicity: it can directly interact with DNA, alter its structure, disrupt transcription factor binding and transcription,90 cause DNA damage and chromosomal aberrations,42,91 induce oxidative stress and apoptosis,91 and significantly affect gene expression profiles.92 There is evidence of its ability to contribute to genomic instability,89 and some Cr(III) compounds (picolinate) have shown mutagenicity and links to organ damage.42 This raises a fundamental question: if the end product of Cr(VI) reduction inside the cell – Cr(III) – is not itself completely inert and safe, but can cause long-term negative cellular and genetic effects, how correct is it to consider the reduction process exclusively as detoxification?

A significant divergence in regulatory approaches to chromium highlights a gap between the known toxicological risks of Cr(VI) and the standards in practice. For public drinking water, major agencies like the World Health Organization (WHO) and the Bureau of Indian Standards (BIS) set a limit of 0.05 mg L−1 for total chromium,93,94 while the U.S. Environmental Protection Agency (US EPA) sets a slightly higher limit of 0.1 mg L−1.95 This choice to regulate total chromium is largely a pragmatic one. The WHO explains this by noting that “current analytical methods and the variable speciation of chromium in water favour a guideline value for total chromium”. Even though this 0.05 mg L−1 value was questioned due to Cr(VI)'s known carcinogenicity, the WHO retained it as a “practical measure… unlikely to give rise to significant risks to health” pending further re-evaluation. In contrast, regulations for occupational settings, where the evidence linking exposure to disease is irrefutable, specifically target the most hazardous form. For instance, the U.S. Occupational Safety and Health Administration (OSHA) mandates a strict permissible exposure limit for airborne hexavalent chromium at 5 μg m−3 over an 8-hour workday, a standard designed to protect workers from the well-documented risk of lung cancer from inhalation.96 This regulatory split is telling. The existence of a stringent, specific standard for Cr(VI) in the workplace acts as an official acknowledgement of which form poses the greatest danger. Consequently, the use of a broader total chromium standard for drinking water appears to be less a statement of safety and more of a practical compromise, dictated by economic and logistical limitations rather than pure toxicological principles.

Another acute area of uncertainty and fierce scientific and regulatory disputes is the carcinogenic mechanism of action (MOA) of low doses of Cr(VI), particularly relevant for drinking water and air regulation.97 The central question of the discussion: does Cr(VI) act through a threshold (non-genotoxic) or non-threshold (genotoxic) mechanism? Arguments for a threshold MOA are often based on data showing cancer in rodents only at very high doses of Cr(VI). These data are interpreted as evidence of a non-mutagenic mechanism of action (MOA), associated, for example, with cytotoxicity and resulting compensatory proliferation of intestinal epithelial cells, rather than with direct DNA damage. Such a mechanism implies the existence of some threshold – a dose below which the risk of cancer development is considered negligibly small. This view is supported by, for example, analyses of the ratio of carcinogenic to genotoxic potency of Cr(VI) upon oral administration, showing its similarity to non-genotoxic agents.98 Also, MOA studies for the inhalation route indicate predominantly negative results in in vivo mutagenicity tests and the role of non-mutagenic events (tissue damage, inflammation),99 while calculations of exposure margins (MOE) for current Cr(VI) levels in air may indicate a low level of risk, questioning standard linear models.100 Based on such data, some regulators establish relatively high permissible Cr(VI) concentrations.97

However, the approach based on a threshold MOA is contested, particularly by the U.S. Environmental Protection Agency (US EPA), which proceeds from the possibility of a non-threshold, genotoxic action (i.e., the assumption that any, even the smallest, dose carries some additional risk) even at low doses.97 Although the direct mutagenicity of Cr(VI) in vivo remains a subject of debate,99 data on the interaction of chromium compounds with DNA in vitro, causing structural changes,76 is presented in support of potential genotoxicity. Additionally, in vitro studies demonstrate Cr(VI)'s ability to cause genomic instability in the form of aneuploidy (changes in chromosome number) at physiologically relevant concentrations.101 The possible contribution of epigenetic mechanisms to carcinogenesis is also considered.100 Based on this assumption of a non-threshold, mutagenic risk, the US EPA's Integrated Risk Information System (IRIS) has derived a cancer slope factor (CSF) for Cr(VI). This CSF is used to calculate health-protective target concentrations in drinking water corresponding to specific cancer risk levels, which can be as low as approximately 0.07 μg L−1 for Cr(VI).97 Such derived values for Cr(VI) are thus 2–3 orders of magnitude lower than the enforceable MCL for total chromium (0.1 mg L−1 (ref. 95)) and also significantly stricter than standards established by other bodies based on threshold approaches or total chromium measurements. This large gap between the official, legally enforced limit for total chromium and the much stricter health advisory level for toxic Cr(VI) highlights a key problem for regulators. Additional questions about the safety of existing lenient standards for total chromium are also raised by data on neurological effects in animals at concentrations close to these limits.61 This lack of consensus on the MOA for low doses of Cr(VI) and how to regulate its specific forms leads to continued regulatory uncertainty and significant differences in risk assessments for the population.

Serious concern is raised by the chronic release of metal ions, including chromium, from widely used CoCr medical implants (orthopedic, dental).67,71,101,102 Unlike external exposure, implants provide constant internal release of ions (Cr, Co, etc.) due to wear and corrosion,103 leading to their elevated levels in patients.67,71,102 Experimental data confirms the biological activity of these ions: in vitro they cause cytotoxic,67 immune,71 and genotoxic101 effects (chromosomal damage). Clinically, this may manifest as inflammation and metallosis103,104 (the pathophysiology of which is insufficiently studied). Of particular concern is the potential carcinogenicity of cobalt and chromium compounds, discussed both in the context of ion release from medical implants and occupational contact. Although a direct causal relationship in humans remains a subject of debate,105 rare cases of aggressive tumors (angiosarcoma,106 osteosarcoma105) near implants have been described. Additionally, a case of lung fibrosis followed by adenocarcinoma has been recorded in a dental technician after many years of contact with dust from cobalt–chromium alloys during polishing; high levels of these metals were found in the patient's lung tissue.107 Nevertheless, the combination of proven in vitro toxicity, hypothetical carcinogenic risk, and unstudied long-term effects creates a serious unresolved risk assessment problem. The absence of established safe limits for ions coming from implants underscores this underestimated danger for millions of people.

Furthermore, accurate assessment of the actual impact of Cr(VI) on humans is complicated by existing difficulties in biomonitoring. Although methods exist for determining chromium in various biological media (urine, blood, exhaled air46,108), the most common and accessible approaches measure total chromium, not reliably differentiating its valence states – toxic Cr(VI) and less toxic Cr(III).46 Given the relatively rapid reduction of Cr(VI) to Cr(III) in the body (especially in blood), measuring total chromium (particularly in urine, which is the main marker46) is an insufficiently specific indicator for assessing exposure specifically to Cr(VI).

In conclusion, it must be emphasized that despite extensive knowledge about Cr(VI) toxicity, the full scale of its danger likely remains substantially underestimated. The scientific contradictions, risk assessment difficulties, knowledge gaps, and monitoring challenges discussed (summarized in Table 1) create significant uncertainty regarding the full extent of chromium's toxicological danger. This uncertainty underscores the need for a precautionary approach, which requires not only intensifying interdisciplinary research and improving monitoring but also revising regulatory frameworks to prioritize prevention. However, a complete risk assessment cannot rely solely on toxicology. To effectively prevent contamination and protect public health, it is equally crucial to understand how hexavalent chromium enters and behaves within the environment. Therefore, the following section will analyze the sources, migration pathways, and transformation processes that define the environmental cycle of Cr(VI).

Table 1 Controversial issues and uncertainties in chromium toxicology
Issue/area Essence of the problem/uncertainties Arguments/data References
Cr(III) toxicity Is Cr(III) truly low-toxic/essential, or can it cause harm? Traditionally low-toxic; but new data shows DNA/cell damage, especially for complexes (picolinate) 42, 47 and 88–92
Regulatory limits Do total chromium limits in drinking water protect public health? Water standards for total Cr set for practicality, contrast with strict Cr(VI)-specific occupational limits, suggesting a regulatory compromise not based purely on toxicity 93–97
Low Cr(VI) dose MOA Threshold (non-genotoxic) or non-threshold (genotoxic) mechanism? Arguments for threshold: cancers in rodents only at very high doses. Arguments against/for genotoxic: EPA stance, aneuploidy, potential DNA interaction, neuro-effects at low levels 76 and 97–101
Medical implants Long-term risks from Cr/Co ion release? In vitro cyto-/genotoxicity; in vivo inflammation, metallosis; rare cancer cases (causality debated); no safe limits set 67, 71 and 101–107
Biomonitoring How to accurately assess Cr(VI) exposure (vs. total Cr)? Urine (total Cr) – non-specific; exhaled breath condensate for (Cr(VI)/Cr(III)) – promising but needs validation 46 and 108
Carcinogenicity for GI tract Is Cr(VI) a GI carcinogen? Conflicting meta-analyses: one suggests risk (stomach), another finds no significant risk 48 and 49


3 Hexavalent chromium in the environmental cycle

After detailed examination of the mechanisms of toxic and carcinogenic action of hexavalent chromium on biological systems, the logical next step is to analyze its behavior in the environment. The entry of Cr(VI) into ecosystems is caused by both extensive anthropogenic activities related to its industrial use and waste disposal, and natural geochemical processes leading to the release and transformation of chromium from rocks.

As a result of this dual origin and its inherent physicochemical properties, Cr(VI) is found in various components of geospheres. Its further ecological fate is determined migration, sorption, and oxidation–reduction transformations, which control its mobility, bioavailability, and persistence in the environment. A deep understanding of the sources of Cr(VI) contamination, its biogeochemical cycle, and factors controlling its distribution and accumulation in natural reservoirs (soils, surface and groundwater) is a necessary condition for adequate assessment of environmental risks and development of effective control and remediation strategies, which will be discussed in Chapter 3.

3.1. Sources of Cr(VI) contamination. Anthropogenic and geogenic factors

Hexavalent chromium (Cr(VI)) enters the environment from both anthropogenic and geogenic sources, with historical attention primarily focused on anthropogenic sources due to their major contribution to global pollution. Numerous industrial processes lead to emissions and discharges of chromium.2–4 Particularly notable are the leather industry, which generates enormous volumes of wastewater and sludges often with high chromium content and potential for Cr(VI) formation,109,110 and the mining and metallurgical complex, leaving behind slags111,112 and ore processing tailings (COPR) where chromium concentration can reach weight percentages.113,114 A critically important aspect is the improper management of these wastes: their direct discharge, storage in unprepared sites, burial together with municipal waste or sewage sludge,115–117 as well as the utilization of ash and slag materials from thermal power plants,118 transform industrial zones and adjacent territories into powerful and long-term sources of contamination. This abandoned sites119,120 and old landfills,113,116 can replenish ecosystems with toxic Cr(VI) for decades,121 forming extensive and difficult-to-eliminate hotspots of soil and groundwater contamination. The scale and persistence of pollution from these well-known anthropogenic sources underscore the complexity of effectively controlling and neutralizing such sites.

Alongside technogenic pollution, geogenic sources make a substantial, and in some regions dominant, contribution to the presence of Cr(VI) in the environment. Chromium is a natural component of the Earth's crust, but its content sharply increases in specific geological formations, primarily in ultrabasic and basic (mafic) rocks.17,122–125 The main mechanism of geogenic chromium entry into water systems includes two stages: first, the slow release of trivalent chromium (Cr(III)) during the weathering of primary chromium-containing minerals;5,122 second, the subsequent oxidation of this relatively inert Cr(III) to the highly mobile and toxic form Cr(VI). Natural processes such as forest fires on chromium-rich soils can also contribute to its mobilization and potential oxidation.126 Intensive weathering and oxidation in favorable geochemical conditions can lead to the formation of significant concentrations of geogenic Cr(VI) in groundwater and surface water, often exceeding drinking water standards.127

In real conditions, it is often extremely difficult to clearly separate the contribution of industrial emissions and natural processes, especially in areas with complex geology and a history of technogenic impact.118,128 The situation is exacerbated by the fact that anthropogenic activity can not only add new Cr(VI) but also actively influence the mobilization and formation of geogenic Cr(VI). For instance, intensive irrigation in agriculture can leach accumulated natural Cr(VI) from the unsaturated zone and transport it to groundwater.122,129 Changes in groundwater exploitation regimes (pumping) affect hydrodynamics and can lead to water contact with previously inactive chromium-containing horizons.130,131 Finally, the creation of local anomalous geochemical conditions, for example, the formation of an alkaline environment in the zone of influence of landfills or thermal power plant ash dumps, can contribute to increased mobility and persistence of Cr(VI).129,131

Anthropogenic activity is the predominant cause of significant contamination: for example, a global analysis of 203 sites contaminated with Cr(VI) showed that 68.95% of them were due to human intervention.1 Industrial sources are capable of creating zones with extremely high chromium content: for instance, at contaminated industrial sites, Cr(VI) concentrations in the topsoil can reach 6100 mg kg−1, and in the water of aquifers beneath such sites – 2090 mg L−1.117 For instance, groundwater at a smelter site showed Cr(VI) concentrations of 162.9 mg L−1 and 234.5 mg L−1 in highly polluted regions,132 and near Chromite Ore Processing Residue (COPR) dumps in the Mexico the Cr(VI) content in groundwater reached 121 mg L−1.114

Geogenic sources, primarily associated with the weathering of ultrabasic and basic rocks, also contribute to the presence of Cr(VI) in the environment. Although peak concentrations from geogenic sources are often lower than those from anthropogenic ones, they can also significantly exceed drinking water standards. For example, in the groundwater of areas with nickel laterites in the Philippines, Cr(VI) concentrations reach 0.213 mg L−1,133 and in mine waters of the Sukinda Valley, India, where chromium is of geogenic origin from ultrabasic rocks, Cr(VI) concentrations can be as high as 4.25 mg L−1.123 Nevertheless, statistical data indicate a difference in contamination levels: at sites with high natural Cr(VI) content, its concentration in water did not exceed 0.2 mg L−1 in 75% of cases, whereas 56.43% of anthropogenically contaminated sites were characterized by Cr(VI) concentrations in water in a wider and often higher range of 0 to 10 mg L−1.

3.2. Migration pathways and transformation of Cr(VI) in geospheres

Having entered the environment hexavalent chromium undergoes a complex cycle of migration and chemical transformations that determine its ecological fate. A fundamental property causing its widespread distribution is the high solubility of the chromate anion, which contrasts sharply with trivalent chromium (Cr(III)) that forms poorly soluble hydroxides or binds firmly to solid phases.33

The key process controlling chromium toxicity and mobility in the environment is redox reactions. On one hand, reduction of Cr(VI) to Cr(III) represents a crucial mechanism of natural attenuation, converting chromium to a less toxic and significantly less mobile form. The main natural reducing agents include divalent iron (Fe(II)),7,33,134 various forms of organic matter,18,119,121 and microorganisms capable of using Cr(VI) as an electron acceptor.109,135 On the other hand, the reverse process – oxidation of Cr(III) to Cr(VI) – can regenerate the toxic form and maintain contamination. Since Cr(III) exists as sparingly soluble forms while Cr(VI) is highly mobile at natural pH, Cr(III) oxidation is prerequisite for chromium enrichment in groundwater.136 This oxidation begins with Cr(III) release from its mineral matrix through weathering processes. Even minerals with relatively low chromium concentrations compared to chromite (e.g., chlorites, pyroxenes) can be significant sources due to their greater weathering susceptibility.137

The primary natural oxidizers of Cr(III) are high-valent manganese oxides (MnOx), particularly mixed-valence Mn(IV/III)-oxides.5,125,137,138 The oxidation mechanism involves Cr(III) adsorption onto Mn-oxide surfaces, followed by electron transfer leading to Cr(VI) formation and manganese reduction.137 Importantly, Mn oxides can promote chromite oxidative dissolution even under anoxic conditions, as demonstrated in basalt-origin soils where high Cr(VI) levels occurred in horizons with co-existing Cr(III)-minerals and Mn(III/IV) oxides.139 However, recent studies have revealed alternative oxidation pathways. Dissolved oxygen (DO), typically present at 1.7–6.39 mg L−1 in high-Cr groundwater,136 contributes both directly and indirectly to oxidation. In sedimentary aquifers, both Mn oxide-mediated and DO-mediated oxidation during silicate weathering generate Cr(VI), particularly with long residence times.136 DO also oxidizes dissolved Mn(II) to Mn-oxides, which then act as chromium oxidants.137

Interestingly, in ophiolitic aquifers, trivalent iron (Fe(III)) present in serpentinites has been identified as a primary oxidant,140 with the Fe2O3/(FeO + Fe2O3) ratio in serpentine controlling Cr concentrations over considerable dissolution extents.140 Additionally, hydrogen peroxide (H2O2) can serve as an important oxidant in ultramafic environments, even under anaerobic conditions.137 Microbial activities also significantly influence the process, with Mn(II)-oxidizing fungi showing varying effects: Cr(III) promotes hyphae-mediated Mn(II) oxidation but inhibits enzyme-mediated processes.141 The oxidation rate and extent depend on Cr(III) speciation, fungal Cr(VI) removal capacity, and organic content.141

The direction of chromium redox transformations is controlled by geochemical conditions, primarily redox potential (Eh) and pH.138,142 Cr(VI) prevails at Eh values above 450–550 mV, while Cr(III) dominates below this threshold.140 The influence of pH is complex: surface-catalyzed Mn(II) oxidation peaks at pH 9,137 while Cr(VI) stability maximizes under alkaline conditions.17,129 At typical groundwater pH (6.5–8.5), Cr(III) solubility remains low (<5 μg L−1), favoring the mobile Cr(VI) form.125 Environmental factors also play crucial roles. Organic matter has dual effects: enhancing Cr(III) release from minerals while potentially inhibiting oxidation through stable complex formation.137 Agricultural activities promote oxidation through ammonium fertilizer-induced acidification and phosphate fertilizer-enhanced chromate desorption.137 Since ultramafic environments show inherent Cr(III) oxidation capacity, retention processes ultimately determine Cr(VI) contamination extent.143

Beyond redox transformations, sorption and desorption at water–solid interfaces critically control Cr(VI) migration. Chromate anions interact with iron/aluminum oxides and clay minerals through electrostatic attraction and surface complexation.18 However, this binding strongly depends on pH: sorption maximizes below pH 6–7 but weakens dramatically above pH 7–8 as mineral surfaces become less positive or negative.5,17,18 Competing anions, particularly phosphate and sulfate, can reduce sorption effectiveness and cause chromate desorption.128,144 These reversible processes provide only temporary retention, and subsequent environmental changes can remobilize chromium.145

Physical transport mechanisms further influence chromium migration. Advection with groundwater flow represents the primary transport mechanism, with Cr(VI) migration rates potentially reaching meters to tens of meters annually.33 Hydrodynamic dispersion gradually expands contamination plumes,130 while hydrogeological properties significantly affect migration patterns. Low-permeability layers can slow vertical migration and create Cr(VI) accumulation zones,117,119 and low flow velocities in sedimentary aquifers promote Cr(VI) generation and accumulation.125,136

The observed chromium behavior at any location results from the complex interplay of these processes: oxidation–reduction, sorption–desorption, and physical transport. This dynamic balance is highly sensitive to site-specific geochemical conditions (pH, mineralogy, organic content) and hydrogeological factors (flow rates, porosity, saturation). The multifactorial nature of these interconnected processes makes accurate prediction of Cr(VI) environmental fate particularly challenging.

3.3. Main accumulation zones of hexavalent chromium

The widespread distribution and persistent accumulation of Cr(VI) in the environment, driven by its migration and transformation, is a significant ecological problem. Its mobility and stability lead to accumulation in natural reservoirs, creating long-term contamination hotspots. These pose substantial risks to ecosystems and human health, demanding comprehensive attention to the numerous and diverse sources of this pervasive pollutant.

Groundwater contamination is of greatest concern, as Cr(VI) actively migrates into this vital resource from a wide spectrum of industrial and geogenic sources,1 facilitated by the high solubility and mobility of chromate ions. Studies worldwide show Cr(VI) distribution in diverse aquifers, from shallow146 to deep.131 Surface waters (rivers, lakes, wetlands) are also contaminated through direct discharges, runoff, or groundwater discharge;120,134 while dilution can occur in large bodies, local levels can be significant. Atmospheric transport of Cr(VI) in aerosols,147 especially near industrial or combustion zones, contributes to wider geographical spread through particle precipitation. Furthermore, chromium can enter biological cycles; plants absorb it from soil and water,135 with accumulation varying by species and conditions, creating a potential pathway to food chains and humans.

Studies worldwide highlight its presence in pronounced industrial zones 130,146 and geologically specific regions.5,7 Industrial hotspots demonstrate the most extreme contamination. Extreme Cr(VI) levels (tens to hundreds of mg L−1) occur near COPR disposal or old chromate facilities.113,114 High concentrations (sometimes mg L−1) are also found near electroplating industries121,146 and metallurgical slag dumps.111,112 Intensive leather production120,148 causes complex wastewater and water body contamination. Mining41,123 and general urban/industrial pollution149,150 also contribute significantly. Alongside these, diverse geogenic sources, primarily weathering of Cr-containing rocks, contribute substantially. Ophiolite regions7,126 often show elevated groundwater Cr(VI) (tens of μg L−1, sometimes >50–100 μg L−1), exceeding standards. The problem is frequently exacerbated by a complex interplay of natural and anthropogenic factors, such as in Greece, where geogenic ophiolite contamination is augmented by industrial sources like ash dumps.115,118 In California, geogenic factors are worsened by anthropogenic impacts like irrigation-induced mobilization.122,129 China shows a full spectrum: industrial site contamination,119,130,131 agricultural impacts, natural Cr(VI) in deep aquifers,127,145 and atmospheric Cr.149

Global Cr(VI) contamination, stemming from multiple sources and complex migration pathways, reflects diverse regional factors and poses profound systemic risks. This environmental cycle is visually summarized in Fig. 3. Considering chromium's wide distribution, stability, complex geochemistry, limited natural attenuation, and critically, its numerous and diverse sources of contamination, these challenges demand stringent control over all sources throughout its cycle. This also necessitates developing and applying effective, though often costly and long-term, cleanup measures to prevent further catastrophic contamination and protect ecological and human health.


image file: d5ra03104d-f3.tif
Fig. 3 Scheme of chromium contamination pathway.

4 Modern approaches to chromium(VI) determination in aqueous media

The scale of environmental contamination with chromium compounds requires the development of mass, rapid, and accessible monitoring methods capable of providing operational control over large territories and in real-time. Traditional instrumental analytical methods, such as inductively coupled plasma mass spectrometry (ICP-MS),151 atomic absorption spectroscopy (AAS),152 and ion chromatography,153 while providing high accuracy and low detection limits, are not suitable for mass screening of chromium contamination. These methods require expensive stationary equipment, lengthy sample preparation, qualified personnel, and cannot be used for on-site analysis. In the context of monitoring vast territories and numerous sampling points, such limitations make traditional methods ineffective for operational contamination control.

The standards for chromium content in drinking water established by international organizations – 50 μg L−1 according to WHO recommendations93 and 100 μg L−1 according to EPA standards95 – serve as guidelines for researchers developing analytical methods. Therefore, the vast majority of developed sensor systems demonstrate detection limits significantly below these regulatory values,27,154–156 making method comparison based solely on this parameter uninformative. Considering the severe toxicological risks and the vast scale of environmental contamination detailed in the preceding chapters, the demands for effective monitoring take on special significance. For large-scale control, the key characteristics are no longer just laboratory accuracy, but rather portability, selectivity, rapid analysis time, and the capability for on-site field operation.

Colorimetric methods remain the simplest to implement in portable devices, as color change can be easily registered using a photodiode or smartphone camera.157,158 The classical method using diphenylcarbazide (DPC) continues to evolve through integration with modern materials.27,159 Immobilization of DPC on various supports allows creating ready-to-use test systems with long shelf life. An important advantage of colorimetric methods is their high selectivity – many systems demonstrate specific response to Cr(VI) even in the presence of high concentrations of other metal ions.27,160

Fluorescent methods provide higher sensitivity through light emission registration, which can be measured using compact photodiodes or portable fluorimeters.29,161,162 Carbon quantum dots of various nature work primarily through fluorescence quenching mechanism – Cr(VI) causes fluorescence intensity decrease due to inner filter effect or energy transfer. Some systems demonstrate more complex “on–off–on” behavior, where fluorescence is first quenched by Cr(VI) and then restored upon addition of reducing agents such as ascorbic acid.161 Such systems allow simultaneous determination of both Cr(VI) and reducing agents. Carbon quantum dots can also operate in dual mode – providing both fluorescent and colorimetric response, which increases analysis reliability.163,164 Metal–organic frameworks (MOFs) stand out among fluorescent materials due to their unique porous structure, which provides not only detection but also Cr(VI) preconcentration.165–167 Luminescent lanthanide-based MOFs demonstrate exceptional selectivity – they can detect Cr(VI) in the presence of multiple other ions without significant interference.168,169 An important advantage is the possibility of creating MOF-based solid-phase sensors in the form of films or test strips, simplifying their practical application.170,171

Electrochemical methods differ in their miniaturization potential. Potentiometric sensors with ion-selective membranes can be easily miniaturized to the size of portable pH meters.172–174 Meanwhile, methods based on anodic stripping voltammetry require more complex equipment for generating potential sweeps and recording voltammograms, although modern screen-printed electrodes and portable potentiostats have significantly simplified their field application.175–177 Electrochemical methods provide high selectivity through selection of Cr(VI) reduction potential, minimizing the influence of other electroactive substances.178,179

Photoelectrochemical sensors register photocurrent generated upon illumination of semiconductor material, requiring a light source and simple current measurement circuit.180–182 Using sunlight as excitation source makes such sensors particularly attractive for field measurements.183,184 While selectivity is intended to arise from the specific interaction of Cr(VI) with photogenerated charge carriers, it may be a significant practical limitation. The total photocurrent signal is susceptible to interference from any other species in a sample that can also react with the electrons or holes.

Microfluidic paper-based devices (μ-PADs) represent a unique platform combining advantages of various detection methods with the simplicity of paper test strips.185,186 Capillary forces provide liquid transport without external pumps, and integration of preconcentration methods allows achieving low detection limits.187

The developed sensor systems are successfully applied for analyzing various sample types. Natural and wastewater feature relatively simple matrices, allowing direct measurements.183,188 Soil analysis requires preliminary extraction, for which special field protocols using alkaline solutions have been developed.189–191 For food products, accounting for matrix effects and possible interferences from organic components is important.192,193

Integration of sensors with smartphones and portable devices opens new possibilities for mass monitoring.28,158,194 Using machine learning algorithms allows improving analysis accuracy and compensating for measurement condition variations.157,195 Creating sensor networks with real-time data transmission enables contamination mapping and spread prediction.30,196

An important trend is the development of multifunctional materials capable of not only detecting but also removing or neutralizing Cr(VI).197,198 Such systems are particularly promising for creating integrated monitoring and remediation devices for contaminated waters, aligning with modern concepts of sustainable development and circular economy.

5 The search for effective methods of Cr(VI) detoxification

The significant toxicological risks and widespread environmental presence of hexavalent chromium (Cr(VI)) have necessitated the development of various removal technologies. This chapter provides a systematic overview of the primary remediation strategies investigated, including adsorption, chemical reduction, electrochemical methods, photocatalysis, ion exchange, membrane filtration, and bioremediation, with their operating principles schematically summarized in Fig. 4. While laboratory studies for these technologies consistently report high removal efficiencies, a critical evaluation is required to assess their practical viability. The chapter, therefore, concludes with a comparative analysis of these methods, evaluating their operational limitations, economic factors, and overall applicability to real-world contamination scenarios to identify the barriers impeding their large-scale implementation.
image file: d5ra03104d-f4.tif
Fig. 4 Schematic representation of the operating principles of main technologies investigated for hexavalent chromium removal from water.

5.1. Adsorption techniques for Cr(VI). Scope and constraints

Adsorption represents an effective method for Cr(VI) removal from aqueous solutions through surface concentration of chromate and dichromate anions at the solid–liquid interface. The process efficiency depends critically on adsorbent surface chemistry and solution pH, with maximum adsorption typically observed under acidic conditions where positively charged surfaces (from protonated functional groups) electrostatically attract Cr(VI) anions. Beyond electrostatic interactions, specific adsorption occurs through coordination or hydrogen bonding with surface functional groups, while certain adsorbents containing reducing components (Fe(II), sulfide groups) can simultaneously reduce toxic Cr(VI) to less harmful Cr(III).199 Adsorbent performance is characterized by adsorption capacity (mg g−1), specific surface area (m2 g−1), and porosity, with adsorption behavior described through isotherms such as Langmuir and Freundlich models.200 Laboratory studies consistently demonstrate promising results with removal efficiencies often exceeding 95%.201–203 The reported maximum adsorption capacities vary dramatically across different material types. Natural sorbents and waste materials typically show moderate values, while specially synthesized nanostructured adsorbents achieve exceptionally high capacities. This wide range reflects the ongoing research drive to optimize performance while maintaining cost-effectiveness. Conditionally, successful laboratory adsorbents can be divided into several groups.
5.1.1 Low-cost natural and waste materials. Their main advantage is availability and low cost. These include natural minerals,204 various biomass wastes,205,206 and industrial wastes.202 Many of them show decent adsorption capacity in laboratory tests, sometimes reaching tens or even more than a hundred mg g−1 (for example, 117 mg g−1 for pistachio shells206), positioning themselves as promising “green” sorbents.
5.1.2 Treated and activated materials. This group includes materials obtained from natural raw materials or wastes through special treatment (for example, acid, alkaline, thermal activation) to improve their sorption properties. Classic examples are activated carbons207,208 and biochars,207,209 which, due to developed porous structure and large specific surface area, often demonstrate increased adsorption capacity compared to the original raw materials (for example, 103 mg g−1 for alkali-treated roots of harpagophytum procumbens versus 77.24 mg g−1 for untreated roots 210).
5.1.3 Synthetic and nanostructured materials. This most extensive and actively developing group includes materials created by targeted synthesis to achieve maximum efficiency. Here figure nanoparticles of metal oxides,211,212 various carbon nanomaterials (CNTs, graphene and its oxide, nanofibers),201,212 metal–organic (MOF)213 and covalent organic (COF) frameworks,19 as well as various composites, often combining nanoparticles with polymer or carbon matrix.200,214,215 For many such materials, very high adsorption capacity values are claimed (hundreds207,215,216 and even thousands214 mg g−1), rapid adsorption kinetics, and the possibility of imparting additional useful properties, for example, magnetic for easy adsorbent separation.201,217

Additionally, for many adsorbents from different groups, the possibility of regeneration and reuse in several cycles with retention of a significant part of the initial efficiency is demonstrated in laboratory conditions.203,207,211 However, the practical implementation of adsorbent regeneration can be a labor-intensive and costly process. Consequently, there is growing interest in cost-effective, single-use applications, which particularly elevates the importance of “green adsorbents” derived from readily available or waste resources.218 In this vein, materials such as Syzygium cumini bark biosorbents have demonstrated exceptional efficacy (adsorption capacity over 500 mg g−1, Freundlich model) in treating tannery wastewater with high Cr(VI) concentrations.219 Materials derived from agricultural waste, such as biochar from rice husks modified with polyethylenimine and KOH (PEI–KOH alkali-rice husk derived biochar220), demonstrate impressive results, exhibiting a Langmuir adsorption capacity of up to 435.7 mg g−1 for Cr(VI). Furthermore, biosorbents from fruit waste, like mango kernel bio-composites, have also shown remarkable performance with Langmuir adsorption capacities reaching 322.58 mg g−1 for Cr(VI), underscoring the potential of minimally processed natural materials.221

5.2. Treating Cr(VI) via chemical pathways

Chemical treatment methods for Cr(VI) removal operate by converting highly soluble and toxic Cr(VI) into less toxic and significantly less soluble Cr(III) through chemical reduction, followed by precipitation or coagulation to form easily separable solid phases. The reduction process involves adding electron-donating reducing agents such as sulfur-based compounds (sulfites) or iron-based materials (ferrous salts, metallic iron, including nanoscale forms) to convert Cr(VI) to the +3 oxidation state.222–225 Following successful reduction, Cr(III) removal is achieved through precipitation and coagulation processes. Since chromium(III) hydroxide (Cr(OH)3) exhibits very low solubility at neutral and slightly alkaline pH, simple pH adjustment can induce precipitation as a solid phase.22 Coagulation efficiency is enhanced by adding iron(III) or aluminum salts, which form voluminous hydroxide flocs (Fe(OH)3, Al(OH)3) that capture Cr(OH)3 particles and facilitate settling.22 These processes are combined for optimal efficiency – iron(II) sulfate, for example, simultaneously reduces Cr(VI) and precipitates both Cr(III) and formed iron(III) as mixed hydroxide precipitates.22

Laboratory and pilot-scale studies demonstrate significant potential for deep purification, consistently achieving Cr(VI) removal efficiencies exceeding 99% using various reducing agents under optimized precipitation and coagulation conditions.22,225,226 Zero-valent iron (ZVI), both as nanoparticles (nZVI) and conventional iron scrap, attracts considerable attention due to iron availability and superior reducing capacity compared to iron salts. Pilot studies using iron scrap in flow columns with subsequent hydroxide precipitation achieved 98.5% total chromium removal at optimal pH 7.6–8.0.22 Classical reducing agents including iron(II) sulfate and sulfites (sodium metabisulfite) regularly demonstrate effectiveness in controlled conditions.227 Their combination with coagulation using iron(III) or aluminum salts reduces total chromium concentrations below drinking water standards (<0.05 mg L−1) with >99% removal efficiency under optimized pilot condition.22 Combined reduction–coagulation–flocculation systems using modern polymer flocculants and specialized reactors achieve >97% Cr(VI) removal.228 Other promising reducing agents include polysulfides, which demonstrated high efficiency (<0.05 mg per L Cr(VI)) in model in situ aquifer treatment experiments,229 and the Fenton process (Fe2+/H2O2), which achieved 92% Cr(VI) removal through combined reduction and co-precipitation mechanisms.230

5.3. Electrochemical approaches to Cr(VI) remediation

Electrochemical methods utilize electrical energy to drive chemical and physicochemical processes for Cr(VI) removal or transformation in aqueous solutions through electrode systems comprising anodes and cathodes with applied current or voltage. The primary approaches include electrocoagulation, direct electrochemical reduction, and capacitive deionization (electrosorption).

Electrocoagulation (EC) generates coagulants in situ through electrochemical dissolution of sacrificial anodes (typically iron or aluminum), releasing Fe2+/Fe3+ or Al3+ ions that immediately hydrolyze to form highly active hydroxide flocs (Fe(OH)3, Al(OH)3).231,232 These flocs effectively bind and precipitate chromium, predominantly as Cr(III) formed through reduction by Fe2+ ions, while also partially adsorbing Cr(VI).233,234 This approach offers superior process control since coagulant generation rates are regulated by current intensity.

Direct electrochemical reduction facilitates electron transfer from cathode surfaces to Cr(VI) ions, reducing them to Cr(III).235,236 Process effectiveness depends critically on cathode material, applied potential, and solution conditions. Indirect reduction may also occur through electrochemically generated reducing agents in solution.235 The resulting Cr(III) can be precipitated due to local pH increases at the cathode.237

Capacitive deionization (CDI) or electrosorption employs porous electrodes with high specific surface areas, often based on activated carbon materials.238 Applied voltage causes ions, including chromate anions, to migrate toward oppositely charged electrodes and become temporarily retained in the electric double layer (EDL) at the electrode-solution interface.238 Unlike conventional adsorption, CDI uses electric potential rather than physicochemical affinity as the driving force. A key advantage is process reversibility – removing or inverting voltage causes accumulated ions to desorb, enabling chemical-free electrode regeneration.

Laboratory and pilot studies demonstrate significant potential for effective and controlled Cr(VI) removal with reduced chemical loading compared to traditional reagent methods. Electrocoagulation has received extensive investigation, with numerous studies reporting very high chromium removal efficiencies. Treatment of real tannery effluents using Al/Ti electrodes with response surface methodology optimization achieved 99.58% Cr(VI) removal.232 Pilot groundwater treatment tests showed EC performance equivalent to chemical coagulation, achieving >99% total chromium removal and meeting drinking water standards.22 Advanced systems include EC with novel electrode materials such as porous NiO/NF, demonstrating 99.5% Cr(VI) removal in 20 minutes while generating hydrogen,23 and hybrid electrocoagulation–capacitive deionization (CDEC) systems reaching standards (<0.05 mg L−1) with claimed energy savings.233

Direct electrochemical reduction and electrosorption methods show promising laboratory-scale results. Studies demonstrate effective Cr(VI) reduction to Cr(III) on various cathode materials,235 with optimized conditions (voltage, temperature, mixing) achieving high extraction rates (87–91% for copper/carbon electrodes) and potential energy savings.236 Capacitive deionization technologies offer reagent-free ion removal with potential selectivity advantages. Novel electrode materials including nanodiamond-modified carbon fabrics237 and composites based on layered double hydroxides and polypyrrole (NiFe-LDH/PPy)238 achieve high specific chromium capacities (up to 39.5 μmol g−1 (ref. 237) or 47.95 mg g−1 with theoretical maximum 111 mg g−1 (ref. 238)) and removal rates up to 95.9% for 100 mg per L Cr(VI).238 Flow-configuration CDI (FCDI) also demonstrates potential for selective Cr(VI) extraction from mixed solutions.239

5.4. Photocatalytic reduction of hexavalent chromium

Photocatalysis employs light energy (ultraviolet or visible radiation) to initiate and accelerate chemical reactions on semiconductor photocatalyst surfaces, with the primary objective of reducing toxic hexavalent chromium to its less toxic and less mobile trivalent form (Cr(III)) in water treatment applications.240–242

The operational principle relies on semiconductor properties where photocatalyst absorption of light quanta with energy sufficient to overcome the band gap generates charge carrier pairs: electrons (e) transition from the valence band to the conduction band, leaving positively charged holes (h+) in the valence band.243 These photogenerated electrons and holes initiate target reactions. Conduction band electrons possess sufficient reducing potential to directly reduce Cr(VI) ions adsorbed on catalyst surfaces to Cr(III), representing the primary pathway for Cr(VI) removal in photocatalysis.244,245 Conversely, holes function as strong oxidizers that can react with water molecules or hydroxide ions to form highly reactive hydroxyl radicals (OH˙), or directly oxidize other substances present in water, including organic pollutants.246 The potential for utilizing solar energy makes this approach particularly attractive, driving extensive research toward developing materials that effectively operate in the visible spectrum rather than traditional UV-active catalysts like TiO2.240,241

Diverse visible light photocatalysts are actively developed and investigated, including individual materials and, particularly important for efficiency enhancement, composites and heterostructures. Studied systems encompass modified oxides (N–TiO2 (ref. 244) or Ag/WO3 as part of Ag/WO3/rGO composite247), various sulfides often acting as heterostructure components (CdS in CdS/LDH,248 Bi2S3 in BiOI/Bi2S3,249 SnS2 in SnS2/GO,250 and complex systems like Fe3O4@rGO@CdS/Bi2S3 (ref. 251)), graphitic carbon nitride (g-C3N4) including substrate-supported forms,252 metal–organic frameworks (MOF),253 covalent organic frameworks (COF),19 and MXenes.24,242 The primary objective in creating composites and heterostructures extends beyond improving light absorption to mainly increasing photogenerated electron–hole separation efficiency. This prevents rapid recombination and enables more electrons to participate in Cr(VI) reduction.

Laboratory conditions demonstrate high rates and degrees of Cr(VI) reduction for many photocatalytic systems. Reports frequently indicate removal (reduction) exceeding 90–98% of Cr(VI) within relatively short timeframes ranging from tens of minutes to several hours.247–249,251,254 Particularly impressive results are achieved with certain heterostructures where nearly complete reduction occurs within 10–40 minutes of visible light irradiation.249 Successful photocatalytic applications are demonstrated not only in model solutions but also in treating real industrial effluents.247 Multifunctional systems are being developed that combine photoreduction capabilities with adsorption, detection, and subsequent chromium processing functions.214

5.5. Ion exchange resins for Cr(VI) removal

Ion exchange represents a reversible and stoichiometric chemical process where unwanted dissolved ions are exchanged for other ions initially bound to solid insoluble materials called ion exchangers or resins, with exchange occurring in equivalent quantities.255 Ion exchangers typically consist of synthetic polymeric resins in granular256 or fiber257 forms, containing fixed ionic groups and mobile counterions capable of exchange.

Since hexavalent chromium exists in water as anions, anion exchange resins (anionites) are employed for its removal.258,259 These resins contain positively charged functional groups (such as quaternary ammonium groups in strongly basic anionites) firmly fixed on polymer matrices, with mobile anions (typically chloride or hydroxide ions) compensating this charge. When contaminated water passes through resin layers (usually in column apparatus), an exchange process occurs where negatively charged Cr(VI) anions from solution displace original mobile anions (e.g., Cl) from resin active sites and bind to the positively charged matrix. Displaced ions transition into the purified water while toxic chromium becomes concentrated in the ion exchanger phase.

When significant portions of resin exchange sites become occupied by (bi)chromate anions (resin “exhaustion”), capacity decreases and regeneration becomes necessary. This is achieved by passing concentrated reagent solutions (NaCl or NaOH) containing high concentrations of original or competing anions through the resin. These anions displace accumulated chromium back into solution as concentrated eluate, restoring the resin to its original form.

Scientific literature presents ion exchange as a mature and potentially highly effective technology for ionic pollutant removal, including Cr(VI). Laboratory and column experiments using Amberlite IRA400 resin for real electroplating effluent purification achieved up to 96.7% Cr(VI) removal.260 Commercial Indion GS-300 resin under optimized conditions demonstrated high adsorption capacity (294 mg g−1) and 98.2% removal efficiency.259 New materials are actively developed including acrylic anion exchange fibers257 and modified structure resins20 showing high capacity and efficiency, plus hybrid systems (NZVI-resin) promising for final drinking water purification from trace Cr(VI) amounts.224

The key advantage emphasized in numerous studies is the regeneration capability and repeated use of ion exchange materials. Laboratory conditions demonstrate successful completion of multiple adsorption–regeneration cycles for various resins, including 30 cycles for Amberlite IRA400 maintaining >97% efficiency260 and 5 cycles for PADD fiber maintaining >95% capacity.257 This regeneration possibility offers prospects for reduced operating costs and decreased solid waste generation compared to non-regenerable adsorbents.

5.6. Membrane based solutions for Cr(VI)

Membrane technologies comprise separation processes utilizing semipermeable membranes – thin barriers capable of passing certain mixture components (typically water) while retaining others (dissolved substances, including Cr(VI) ions). Process driving forces include pressure differences, electrical potentials, or concentration gradients. All these technologies employ membranes as key selective elements separating initial flows into purified water (permeate) and concentrated waste streams (concentrate or retentate).261

The main methods include nanofiltration (NF) and reverse osmosis (RO), which are baromembrane processes where high pressure forces water through membranes that retain Cr(VI) ions through sieving effects and electrostatic interactions.21,262,263 Studies demonstrate that NF membranes effectively retain multivalent ions, achieving 95–96.5% Cr(VI) rejection rates for commercial membranes treating industrial effluents,21 while RO membranes with denser structures provide nearly complete chromium and salt removal with rejection rates exceeding 99%.264 Efficiency can be enhanced through advanced approaches such as micelle-enhanced nanofiltration (MENF), achieving up to 98.5% Cr(VI) removal.262 Electrodialysis (ED) employs a different principle where electric fields cause Cr(VI) ions to migrate through selective anion exchange membranes toward anodes, concentrating them in separate streams.265 ED demonstrates potential for selective Cr(VI) transfer266 and is studied in combination with other methods including photocatalysis244 and CDI.267 Other membrane approaches under investigation include liquid membranes with selective carriers267 and hybrid processes using functionalized membranes (often nanofiber),215,268–271 which can combine filtration with surface adsorption or reaction.

Recent research has focused extensively on developing new membrane materials with improved or hybrid properties. Electrospun nanofiber membranes attract significant interest due to their high porosity, large specific surface areas, and functionalization possibilities.271 Studies report composite nanofiber membrane development, including polyacrylonitrile (PAN) with polyaniline (PANI) and polysulfide coatings215 or recycled PVC with cationic groups,269 which combine filtration with Cr(VI) adsorption and demonstrate high removal rates (>90%) in dynamic tests on model industrial effluents. These membranes also show good regeneration capability in laboratory conditions (10–12 cycles). Mixed matrix membranes incorporating functional fillers such as modified g-C3N4 (ref. 270) or boehmite nanoparticles with polyphenols268 into polymer bases (polysulfone or polyethersulfone) achieve very high Cr(VI) rejection rates (>92% and even >99%) while maintaining good water permeability. Liquid membranes in laboratory flow systems demonstrate high (>98%) and stable Cr(VI) removal efficiency when utilizing suitable carriers.272

5.7. Bioremediation strategies for hexavalent chromium

Biological treatment methods, or bioremediation, utilize the natural abilities of living organisms (microbes and plants) for Cr(VI) removal, detoxification, or stabilization in environmental systems.273,274 These approaches attract attention as potentially environmentally friendly and economical solutions operating through several key mechanisms. Biosorption represents a predominantly passive process where Cr(VI) or Cr(III) ions bind to microbial cell surfaces (bacteria, fungi, algae) through physicochemical interactions with cell wall components, capsules, or extracellular polymeric substances without metabolic energy expenditure.274 Bioaccumulation involves active, energy-dependent processes where living cells absorb and accumulate chromium ions intracellularly through specialized membrane transport systems.274 Bioreduction is considered the most promising mechanism, as microorganisms use enzyme systems (chromate reductases) to reduce highly toxic Cr(VI) to less toxic and less mobile Cr(III), which often precipitates as insoluble compounds.274 Phytoextraction employs plants' ability to absorb chromium through root systems and transport it to aboveground parts for accumulation, with hyperaccumulator plants capable of concentrating metals at high levels.275

Microbial remediation research focuses primarily on Cr(VI) bioreduction as the key detoxification mechanism. Studies report isolation of bacterial and fungal strains from contaminated environments with remarkable Cr(VI) resistance, surviving concentrations in thousands of mg L−1.276 Resistant strains from genera including Bacillus,276–278 Micrococcus,276 Rhodobacter,25 and Trichoderma279 demonstrate high bioreduction efficiency in laboratory conditions, often achieving 90–100% Cr(VI) to Cr(III) conversion within hours or days under optimized conditions. Reported achievements include complete reduction of 100 mg per L Cr(VI) in 48 hours by bacterial isolates from tannery effluents276 and 92–98% Cr(VI) removal in bioreactors.25,277,280 Microalgae and cyanobacteria demonstrate chromium removal capabilities by accumulating it in biomass, potentially useful for biofuel production.281,282

Phytoremediation studies have identified hyperaccumulator plants capable of high-level chromium tissue accumulation, such as aquatic plant Callitriche cophocarpa accumulating up to 1274 mg kg−1.26 Particularly promising is the synergism between plants and microorganisms, where plant inoculation with specific endophytic bacteria or mycorrhizal fungi significantly increases chromium resistance, improves growth, and substantially enhances accumulation or removal efficiency. Combined use of Trichoderma and Rhizomucor fungi with King Grass increased plant Cr accumulation by 64% and total soil Cr removal by 34% compared to plants alone.279 Bacterial consortium inoculation of Callitriche cophocarpa significantly improved Cr(VI) phytoextraction and plant physiological status.26

Biological approaches demonstrate broad possibilities for Cr(VI) interaction including binding, accumulation, and detoxification through reduction in laboratory and limited field conditions. Their key advantage lies in fundamental biocompatibility, making them particularly attractive for in situ remediation of contaminated natural environments through introduction of adapted microbial cultures or specific plant species in contaminated zones.283

The scientific response to Cr(VI) contamination has produced a wide spectrum of remediation technologies, from established physicochemical methods to emerging biological and photocatalytic systems. These approaches are fundamentally distinct, involving either the physical transfer of chromium between phases or its chemical transformation into the less mobile Cr(III) state via reduction. The primary features and operational principles of these varied approaches are summarized in Table 2.

Table 2 Overview of primary Cr(VI) remediation technologies
Method Features and advantages Key materials References
Adsorption Utilizes low-cost natural and waste materials. Achieves high adsorption capacities with synthetic materials. Allows for regeneration and reuse Biomass, activated carbons, biochars, metal–organic frameworks (MOFs), nanocomposites 19, 199–221 and 290–293
Chemical reduction and precipitation A simple and scalable technology with high removal efficiencies (>99% in pilot studies). Zero-valent iron (ZVI) is an available and effective reducing agent Ferrous salts (e.g., FeSO4), sulfites, zero-valent iron (ZVI), scrap iron 22, 199 and 222–230
Electrochemical methods Provides a high degree of process control via current regulation. High removal efficiencies (>99% for EC) are demonstrated. Capacitive deionization offers reagent-free regeneration Sacrificial anodes (Fe, Al) for electrocoagulation, porous carbon electrodes for CDI 23, 231–239 and 294
Photocatalysis Utilizes light energy, including solar, offering a potentially sustainable approach. High reduction rates (>90–98%) are shown in laboratory settings TiO2, g-C3N4, metal–organic frameworks (MOFs), MXenes 19, 24, 214, 240–245, 247–252 and 254
Ion exchange process A reversible process that allows for multiple regeneration and reuse cycles while maintaining high efficiency. High capacity is shown with commercial resins Anion exchange resins (e.g., Amberlite IRA400), acrylic anion exchange fibers 20, 224 and 256–260
Membrane technologies Achieves very high rejection rates, often exceeding 95% for nanofiltration (NF) and 99% for reverse osmosis (RO). Can be combined with other processes in hybrid membranes NF and RO polymer membranes, electrospun nanofiber membranes, mixed matrix membranes 21, 215, 244, 261–263, 265, 267–272 and 295
Bioremediation A potentially eco-friendly and economical solution. Bioreduction provides a promising detoxification pathway. Can be applied for in situ treatment of contaminated sites Bacteria, fungi, hyperaccumulator plants, microalgae 25, 26, 36, 273–283, 296 and 297


5.8. Comparative assessment of Cr(VI) remediation technologies

Comparative analysis of the reviewed chromium remediation methods reveals significant differences in their practical applicability and effectiveness. Removal efficiency varies substantially between methods and strongly depends on application conditions. Under laboratory conditions, many technologies demonstrate impressive results: adsorption on nanomaterials achieves 93–99.99% removal,284 electrocoagulation shows 95–100% efficiency,285 chemical precipitation provides 98–99% removal,286 and photocatalytic reduction achieves 95–100% within relatively short timeframes.37

However, it is worth noting that nearly all published remediation methods report such high removal efficiencies. This phenomenon is partly a result of publication bias, as high performance is often a prerequisite for acceptance in reputable journals. Consequently, removal efficiency as a percentage has become a less discerning metric for comparing different published technologies; a high value is practically a given. This shifts the focus to more critical, real-world criteria like cost, scalability, and overall practical applicability.

The percentage removal metric itself is also inherently biased. Achieving 99% removal is significantly easier when treating water with a high initial Cr(VI) concentration (e.g., reducing it from 100 mg L−1 to 1 mg L−1) than when attempting to remove trace amounts to meet stringent regulatory standards (e.g., from 0.1 mg L−1 to 0.001 mg L−1). The ultimate goal of any water treatment is to reach concentrations below these regulatory limits. It is precisely the removal of these final, trace concentrations that poses the greatest challenge, due to fundamental scientific barriers. Thermodynamically, the driving force for processes like adsorption or reaction diminishes as the concentration gradient between the solution and the material surface decreases. Kinetically, the probability of a successful collision between a chromium ion and an active site on the remediation agent becomes much lower at dilute concentrations. Therefore, a more rigorous assessment of any new technology should focus on its ability to reach specific target final concentrations from realistic initial levels, rather than on an often-deceptive removal percentage. This principle of realistic assessment must also extend to the testing environment. The high efficiencies reported in laboratories are achieved under idealized conditions, whereas real efficiency under industrial conditions may be significantly lower due to the influence of competing ions and complex wastewater composition.287–289

The critical dependence on pH represents a fundamental limitation for most methods. Adsorption typically requires acidic conditions (pH 2–4) for maximum efficiency,291,292 while real industrial effluents often have neutral or alkaline pH,298 necessitating costly pH adjustment steps. Similarly, ion exchange faces challenges from the chemical aggressiveness of chromate ions, which can oxidize and destroy both the polymer matrix and functional groups of resins.258 During multiple sorption–desorption cycles, Cr(VI) can be partially reduced to Cr(III) on the resin,20,257,258 indicating undesirable side reactions and complicating regeneration. The presence of competing anions (phosphates, chlorides, nitrates) further reduces the practical efficiency of ion exchange by competing for active sites.289

Membrane technologies face serious fouling problems, where surfaces and pores become progressively clogged with suspended particles, colloids, organic substances, salt deposits, or biofilms.295 This leads to performance decline, increased energy consumption, and shortened membrane lifetime. Regular chemical cleaning with aggressive reagents is necessary but can damage membranes and generate additional waste streams requiring treatment.295 Furthermore, membrane processes merely redistribute pollutants rather than destroy them, generating highly concentrated waste streams that require additional treatment stages.

Cost parameters vary widely among technologies. Bioremediation and low-cost adsorbents from waste materials are positioned as the most economically accessible solutions.36,299,300 Chemical precipitation shows the lowest capital costs with potentially low operating expenses,286 though it generates large volumes of toxic chromium hydroxide sludge requiring landfill disposal.286,301 Electrochemical methods face limitations due to high electricity consumption and electrode replacement costs.285 The production cost of advanced nanomaterials can be 1000 times higher than activated carbon,293 severely limiting their practical application. For photocatalytic systems, while solar-driven processes offer minimal operational energy costs,37 the initial investment in reactor design and catalyst preparation, along with challenges in catalyst recovery and long-term stability, should impact economic viability.

Energy consumption represents a critical factor determining both economic feasibility and environmental sustainability. Biological methods, chemical precipitation, and adsorption require minimal electricity input.36,284 Solar-driven photocatalysis theoretically offers zero operational energy costs during daylight hours,37 though practical implementation faces challenges from light source variability and reactor design requirements. Electrochemical methods are inherently energy-intensive, with electrodialysis and electrocoagulation requiring continuous power input.285,294 Membrane processes, especially reverse osmosis, demand significant energy for pressure generation,8 making them among the most energy-consuming technologies.

The scalability of technologies from laboratory to industrial scale presents serious challenges. Most research on advanced adsorbents and photocatalysts has been conducted under idealized conditions using synthetic wastewater, with insufficient data on pilot or industrial-scale applications.293 The synthesis of complex nanostructures remains technically challenging and economically unfeasible for large-scale production. Biological methods face difficulties when scaling due to microorganism sensitivity to high pollutant concentrations and variable environmental conditions.36,296 The slow kinetics of biological processes, requiring weeks to months for significant effect, further limits their industrial applicability. Chemical methods and electrocoagulation demonstrate better scalability due to their relative simplicity and established industrial implementation.285,299

A fundamental problem inherent to all removal methods is the generation of secondary waste. Chromium, being a chemical element, cannot be destroyed but only transformed from one form to another or concentrated in different phases. Chemical precipitation generates large volumes of chromium hydroxide sludge,286,301 electrochemical methods produce metal-laden sludge and spent electrodes,285,286 membrane technologies create concentrated retentates requiring further treatment,8 and ion exchange produces toxic regeneration eluates.39 Even seemingly green approaches like adsorption on biomass or biological treatment ultimately generate chromium-laden solid waste requiring special disposal. This universal challenge highlights that Cr(VI) remediation merely transforms the contamination problem rather than solving it completely.

The most critical limitation across all technologies, visually captured by the iceberg metaphor in Fig. 5, is their focus on treatment of wastewater – the small, visible tip of the problem – rather than addressing the vast scale of existing environmental contamination. Among reviewed methods, only bioremediation,297 nanoscale zero-valent iron injection,302,303 chemical stabilization/solidification,301 phytoremediation,299,301 and to some extent in situ photocatalytic treatment (in surface waters) can be applied directly at contamination sites. However, these in situ approaches face their own limitations: bioremediation suffers from slow kinetics and unpredictable performance, nZVI has limited reactive lifetime and potential for pollutant remobilization,302 phytoremediation is restricted to shallow contamination and low metal concentrations,301 while photocatalytic treatment requires adequate light penetration and catalyst stability.37


image file: d5ra03104d-f5.tif
Fig. 5 Metaphorical representation of the Cr(VI) contaminated sites problem.

Considering environmental sustainability and the principles of green chemistry, the ideal remediation technology should minimize secondary waste generation, utilize renewable energy sources, avoid hazardous chemicals, and enable pollutant recovery or transformation into benign products. Based on these criteria, biological methods and solar-driven photocatalysis emerge as the most environmentally compatible approaches, despite their current limitations. Bioremediation offers the unique advantage of being a truly biocompatible process that can potentially restore damaged ecosystems, though its effectiveness remains unpredictable.36,297 Photocatalytic treatment, particularly when utilizing abundant materials like TiO2 and solar energy, represents a promising green technology,37 though challenges in scaling and real-world application persist. Hybrid approaches combining biological and photocatalytic processes, or integrating adsorption with photocatalytic regeneration, may offer synergistic benefits that overcome individual method limitations. A comparative visualization of these remediation technologies across performance indicators is presented in Fig. 6.


image file: d5ra03104d-f6.tif
Fig. 6 Comparative analysis of the main Cr(VI) remediation technologies using radar charts. The axes for cost, energy demand, and secondary waste generation are on an inverted scale, where a higher value represents lower value.

The development of truly sustainable Cr(VI) remediation necessitates a change in focus from simply transferring contamination between phases to creating technologies that can effectively immobilize chromium in geochemically stable forms or enable its recovery for reuse. This necessitates interdisciplinary collaboration between materials scientists, environmental engineers, and policymakers to develop economically viable solutions that address both immediate treatment needs and long-term environmental protection. Until such breakthrough technologies emerge, the selection of remediation methods will continue to involve compromises between efficiency, cost, and environmental impact, with no single technology providing a universal solution to the chromium contamination crisis.

6 Summary and prospects

This comprehensive review reveals a fundamental disconnect between our sophisticated understanding of hexavalent chromium toxicity and our limited ability to address environmental contamination. While research has elucidated molecular mechanisms of Cr(VI) toxicity with remarkable precision – from cellular entry through oxidative damage cascades to genomic instability – this knowledge has not translated into proportionally effective environmental solutions. The paradox extends beyond Cr(VI) itself: emerging evidence suggests that Cr(III), traditionally considered safe, may possess significant biological activity when formed intracellularly or introduced as certain complexes. Even metallic chromium from medical implants presents underappreciated risks through continuous ion release. These findings challenge the fundamental assumption that reduction of Cr(VI) to Cr(III) represents true detoxification, suggesting instead that current regulatory frameworks and remediation strategies may be built on incomplete toxicological understanding.

The scale of the problem becomes apparent when examining contamination patterns. While anthropogenic sources dominate both in frequency and concentration, the widespread occurrence of geogenic Cr(VI) adds complexity to attribution and management. Most critically, the inherent chemistry of chromium – particularly the reversibility of redox transformations between Cr(III) and Cr(VI) under environmental conditions – means that contamination is not a static problem but a dynamic process. The presence of manganese oxides and other natural oxidants can regenerate toxic Cr(VI) from supposedly safe Cr(III) deposits, creating persistent contamination cycles that current remediation approaches fail to address adequately.

Analysis of remediation practices reveals troubling feedback mechanisms that perpetuate rather than resolve contamination. Chemical precipitation, widely adopted for its economic feasibility, generates chromium-containing sludges requiring disposal. These disposal sites, particularly when containing manganese oxides or experiencing pH changes, can become secondary sources through re-oxidation of precipitated Cr(III). Similarly, ion exchange resins accumulate chromium that must ultimately be managed, while membrane technologies concentrate pollutants without destroying them. Even biological treatment, often promoted as “green”, produces chromium-laden biomass requiring disposal.

The economic dynamics of chromium management create additional feedback loops. The high cost of advanced treatment technologies drives industries toward cheaper alternatives, often resulting in inadequate treatment or improper disposal. This is particularly evident in regions with weak regulatory enforcement, where short-term economic considerations override long-term environmental costs. Historical examples, such as chromite ore processing residue (COPR) disposal sites, demonstrate how decades of cost-effective practices create contamination legacies requiring orders of magnitude more resources to address than proper initial management would have required.

The proliferation of studies reporting near-perfect removal efficiencies under controlled laboratory conditions contrasts starkly with continued environmental contamination, suggesting that the limiting factor is not chemical feasibility but practical implementation. Most concerning is the tendency in materials science to develop complex nanocomposites or advanced materials first, then subsequently evaluate their application for various purposes including chromium removal. This approach, while producing impressive laboratory results, rarely considers scalability, cost-effectiveness, or real-world performance from the outset.

The focus on wastewater treatment, while important, has overshadowed equally critical challenges in soil and groundwater remediation. The vast majority of developed technologies target dissolved Cr(VI) in relatively controlled matrices, yet contaminated soils and aquifers represent the largest environmental reservoirs of chromium. The few technologies applicable to these matrices – primarily in situ chemical reduction or bioremediation – face significant limitations in heterogeneous subsurface environments. This gap between research focus and environmental need suggests that future development must prioritize technologies specifically designed for large-scale, in situ application rather than adapted from wastewater treatment approaches.

Recent advances in sensor technology offer transformative potential for chromium management, though this potential remains largely unrealized. The development of portable, rapid detection methods with sensitivity comparable to laboratory instruments enables continuous, distributed monitoring of contamination. Such capabilities could fundamentally change management strategies from periodic sampling to real-time surveillance, allowing early detection of contamination events and adaptive treatment responses. When integrated with data analytics and predictive modeling, these sensing networks could provide unprecedented understanding of chromium fate and transport in complex environments.

However, the true value of advanced monitoring extends beyond detection to enabling more nuanced management strategies. For contaminated sites where complete remediation is impractical, continuous monitoring could support risk-based management approaches that focus on preventing exposure rather than achieving arbitrary cleanup standards. This represents a pragmatic recognition that for many legacy contamination sites, perpetual management may be more realistic than remediation.

The evidence presented throughout this review points toward the necessity of fundamental shifts in how we approach chromium contamination. Rather than continuing to pursue increasingly sophisticated end-of-pipe solutions, emphasis must shift toward prevention and circular economy principles. This requires reimagining industrial processes to minimize chromium use, prevent Cr(III) oxidation, and enable recovery and reuse rather than disposal. Where chromium use remains essential, closed-loop systems that maintain chromium in controlled chemical states throughout its lifecycle offer more promise than treatment of dispersed contamination.

For existing contamination, differentiated strategies based on contamination characteristics and site conditions are essential. High-concentration industrial releases may warrant aggressive chemical treatment despite secondary waste generation, while diffuse geogenic contamination might be better managed through stabilization and monitoring. Legacy contaminated sites, particularly those with deep subsurface contamination, may require acceptance of long-term containment and management rather than pursuit of complete remediation.

The chromium contamination crisis, as revealed through this comprehensive analysis, represents a more complex and persistent challenge than traditionally acknowledged. The combination of widespread historical contamination, ongoing industrial use, natural geogenic sources, reversible chemistry, and incomplete toxicological understanding creates a problem resistant to simple technical solutions. Moreover, the discovery that all chromium forms – including supposedly safe Cr(III) and metallic chromium – may pose health risks under certain conditions necessitates fundamental reconsideration of management approaches.

Moving forward requires integration of multiple strategies rather than reliance on any single approach. Prevention must become the primary focus, with treatment reserved for situations where prevention fails. This demands close collaboration between researchers, industries, and regulators to develop practical, scalable solutions designed from inception for real-world implementation. Research priorities must shift from demonstrating theoretical possibilities to solving practical implementation challenges. The development of materials and technologies must be guided by clear understanding of deployment contexts, economic constraints, and lifecycle implications.

Perhaps most importantly, the scientific community must communicate honestly about the limitations of current approaches and the likely persistence of chromium contamination. Rather than perpetuating unrealistic expectations of complete remediation, effort should focus on developing robust, long-term management strategies that protect human health and ecosystems while acknowledging the practical constraints of chemistry, economics, and scale. Only through such realistic assessment and integrated action can we hope to minimize the ongoing impacts of this persistent environmental challenge.

Data availability

No primary research results, software or code have been included and no new data were generated or analysed as part of this review.

Author contributions

Yaroslav Zhigalenok: conceptualization, methodology, investigation, visualization, writing – original draft, writing – review & editing. Aigerim Tazhibayeva: validation, writing – original draft, writing – review & editing. Saule Kokhmetova: conceptualization, supervision, project administration, funding acquisition, writing – review & editing. Alena Starodubtseva: investigation, data curation, writing – review & editing. Tatyana Kan: investigation, resources, writing – review & editing. Dana Isbergenova: conceptualization, investigation, writing – review & editing. Fyodor Malchik: methodology, formal analysis, writing – review & editing.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

This work was supported by the Ministry of Science and Higher Education of the Republic of Kazakhstan (Grant No. AP19178014). During the preparation of this work the authors used the Gemini 2.5 Pro, a large language model from Google in order to improve English grammar and enhance its readability and stylistic qualities. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.

Notes and references

  1. H. Xu, H. Zhang, C. Qin, X. Li, D. Xu and Y. Zhao, Chemosphere, 2024, 360, 142395 CrossRef CAS PubMed.
  2. D. E. Kimbrough, C. Yoram, W. M. Arthur, C. Lynn and C. Mabuni, Crit. Rev. Environ. Sci. Technol., 1999, 29, 1–46 CrossRef CAS.
  3. J. M. Heikoop, T. M. Johnson, K. H. Birdsell, P. Longmire, D. D. Hickmott, E. P. Jacobs, D. E. Broxton, D. Katzman, V. V. Vesselinov, M. Ding, D. T. Vaniman, S. L. Reneau, T. J. Goering, J. Glessner and A. Basu, Chem. Geol., 2014, 373, 1–9 CrossRef CAS.
  4. J. Song, B. Dubey, Y.-C. Jang, T. Townsend and H. Solo-Gabriele, J. Hazard. Mater., 2006, 128, 280–288 CrossRef CAS PubMed.
  5. R. Bertolo, C. Bourotte, R. Hirata, L. Marcolan and O. Sracek, Appl. Geochem., 2011, 26, 1353–1363 CrossRef CAS.
  6. M. A. Islam, M. J. Angove and D. W. Morton, Environ. Nanotechnol., Monit. Manage., 2019, 12, 100267 Search PubMed.
  7. M. Economou-Eliopoulos, R. Frei and C. Atsarou, Catena, 2014, 122, 216–228 CrossRef CAS.
  8. H. Peng and J. Guo, Environ. Chem. Lett., 2020, 18, 2055–2068 CrossRef CAS.
  9. B. Xia, L. Yang, H. Huang, L. Pang, G. Hu, Q. Liu, J. Yuan, J. Liu, Y. Xia and Z. Zhuang, Toxicol. Lett., 2011, 205, 140–145 CrossRef CAS PubMed.
  10. S. De Flora, Carcinogenesis, 2000, 21, 533–541 CrossRef CAS PubMed.
  11. S. Kamila, P. Shaw, S. Islam and A. Chattopadhyay, Sci. Total Environ., 2023, 890, 164395 CrossRef CAS PubMed.
  12. I. Meaza, A. R. Williams, H. Lu, J. C. Kouokam, J. H. Toyoda, T. J. Croom-Perez, S. S. Wise, A. E.-M. Aboueissa and J. P. Wise, Toxicol. Appl. Pharmacol., 2023, 479, 116711 CrossRef CAS PubMed.
  13. C. Long, Z. Su, G. Hu, Q. Zhang, Y. Zhang, T. Chen, S. Hong, L. Su and G. Jia, Chemosphere, 2024, 349, 140918 CrossRef CAS PubMed.
  14. J. F. Cerveira, M. Sánchez-Aragó, A. M. Urbano and J. M. Cuezva, FEBS Open Bio, 2014, 4, 594–601 CrossRef CAS PubMed.
  15. J. Lou, S. Yu, L. Feng, X. Guo, M. Wang, A. T. Branco, T. Li and B. Lemos, Environ. Int., 2021, 153, 106525 CrossRef CAS PubMed.
  16. K. Straif, L. Benbrahim-Tallaa, R. Baan, Y. Grosse, B. Secretan, F. El Ghissassi, V. Bouvard, N. Guha, C. Freeman, L. Galichet and V. Cogliano, Lancet Oncol., 2009, 10, 453–454 CrossRef PubMed.
  17. A. Stefánsson, I. Gunnarsson, H. Kaasalainen and S. Arnórsson, Appl. Geochem., 2015, 62, 200–206 CrossRef.
  18. Y. Cao, Z. Dai, C. Zhang, L. Ding, S. Yin and M. Reza Soltanian, Appl. Geochem., 2024, 173, 106136 CrossRef CAS.
  19. S. Samajdar, S. A. Golda, S. K. Lakhera and S. Ghosh, Chemosphere, 2024, 350, 141028 CrossRef CAS PubMed.
  20. G. Wójcik, V. Neagu and I. Bunia, J. Hazard. Mater., 2011, 190, 544–552 CrossRef PubMed.
  21. G. Basaran, D. Kavak, N. Dizge, Y. Asci, M. Solener and B. Ozbey, Desalin. Water Treat., 2016, 57, 21870–21880 CrossRef CAS.
  22. A. Martín-Domínguez, M. L. Rivera-Huerta, S. Pérez-Castrejón, S. E. Garrido-Hoyos, I. E. Villegas-Mendoza, S. L. Gelover-Santiago, P. Drogui and G. Buelna, Sep. Purif. Technol., 2018, 200, 266–272 CrossRef.
  23. Z. Wang, Q. Shen, J. Xue, R. Guan, Q. Li, X. Liu, H. Jia and Y. Wu, Chem. Eng. J., 2020, 402, 126151 CrossRef CAS.
  24. N. S. Jamaluddin, N. H. Alias, S. Samitsu, N. H. Othman, J. Jaafar, F. Marpani, W. J. Lau and Y. Z. Tan, J. Environ. Chem. Eng., 2022, 10, 108665 CrossRef CAS.
  25. H.-T. Mao, L.-X. Chen, M.-Y. Zhang, Q.-Y. Shi, H. Xu, D.-Y. Zhang, Z.-W. Zhang, M. Yuan, S. Yuan, H.-Y. Zhang, Y.-Q. Su and Y.-E. Chen, Environ. Pollut., 2023, 319, 120973 CrossRef CAS PubMed.
  26. J. Augustynowicz, A. Kowalczyk, D. Latowski, A. Kołton, E. Sitek and A. Kostecka-Gugała, Sci. Total Environ., 2024, 922, 171327 CrossRef CAS PubMed.
  27. S. Meshram and R. Bandyopadhyaya, Talanta, 2025, 291, 127803 CrossRef CAS PubMed.
  28. L. Li, X. Dong, J. Chen, J. Xiao, L. Zeng, Z. Huang and Z. Zou, Microchem. J., 2024, 197, 109841 CrossRef CAS.
  29. L. Khoshmaram, M. Emami, R. Jalili and A. Imani-Nabiyyi, Anal. Methods, 2024, 16, 6546–6552 RSC.
  30. S. Dutta, T. M. Christy, W. McCall and P. Kurup, Environ. Earth Sci., 2021, 80, 241 CrossRef CAS.
  31. J. P. Wise, J. L. Young, J. Cai and L. Cai, Environ. Int., 2022, 158, 106877 CrossRef CAS PubMed.
  32. M. D. Cohen, K. Biserka, K. B. Catherine and M. Costa, Crit. Rev. Toxicol., 1993, 23, 255–281 CrossRef CAS PubMed.
  33. F. C. Richard and A. C. M. Bourg, Water Res., 1991, 25, 807–816 CrossRef CAS.
  34. S. Liu, L. Zhang, H. Kim, J. Sun and J. Yoon, Coord. Chem. Rev., 2024, 501, 215575 CrossRef CAS.
  35. P. Biswas, A. K. Karn, P. Balasubramanian and P. G. Kale, Biosens. Bioelectron., 2017, 94, 589–604 CrossRef CAS PubMed.
  36. X. Tang, Y. Huang, Y. Li, L. Wang, X. Pei, D. Zhou, P. He and S. S. Hughes, Ecotoxicol. Environ. Saf., 2021, 208, 111699 CrossRef CAS PubMed.
  37. R. Djellabi, P. Su, E. A. Elimian, V. Poliukhova, S. Nouacer, I. A. Abdelhafeez, N. Abderrahim, D. Aboagye, V. V. Andhalkar, W. Nabgan, S. Rtimi and S. Contreras, J. Water Process Eng., 2022, 50, 103301 CrossRef.
  38. K. Pandey, B. S. Saharan, R. Kumar, D. Jabborova and J. S. Duhan, J. Xenobiot., 2024, 14, 1670–1696 CrossRef CAS PubMed.
  39. M. K. Barman, A. Bhattarai and B. Saha, Vietnam J. Chem., 2023, 61, 533–550 CrossRef CAS.
  40. S. Xie, Green Chem. Lett. Rev., 2024, 17, 2356614 CrossRef.
  41. S. Mohanty, A. Benya, S. Hota, M. S. Kumar and S. Singh, Environ. Chem. Ecotoxicol., 2023, 5, 46–54 CrossRef CAS.
  42. D. Bagchi, S. J. Stohs, B. W. Downs, M. Bagchi and H. G. Preuss, Toxicology, 2002, 180, 5–22 CrossRef CAS PubMed.
  43. R. Chakraborty, K. Renu, M. A. Eladl, M. El-Sherbiny, D. M. A. Elsherbini, A. K. Mirza, B. Vellingiri, M. Iyer, A. Dey and A. Valsala Gopalakrishnan, Biomed. Pharmacother., 2022, 151, 113119 CrossRef CAS PubMed.
  44. J. Zhang, R. Wang, G. Qu, J. Ma, Y. Wang, D. Zhang, X. Zhou and L. Liu, Leg. Med., 2024, 71, 102524 CrossRef CAS PubMed.
  45. C. Long, G. Hu, P. Zheng, T. Chen, Z. Su, Y. Zhang, C. Ding, F. Peng, S. Yu, T. Wang and G. Jia, Toxicol. Lett., 2021, 349, 92–100 CrossRef CAS PubMed.
  46. J. Verdonck, R.-C. Duca, K. S. Galea, I. Iavicoli, K. Poels, Z. N. Töreyin, J. Vanoirbeek and L. Godderis, Int. J. Hyg Environ. Health, 2021, 236, 113799 CrossRef CAS PubMed.
  47. T. L. DesMarias and M. Costa, Curr. Opin. Toxicol., 2019, 14, 1–7 CrossRef PubMed.
  48. R. Welling, J. J. Beaumont, S. J. Petersen, G. V Alexeeff and C. Steinmaus, Occup. Environ. Med., 2015, 72, 151–159 CrossRef PubMed.
  49. N. M. Gatto, M. A. Kelsh, D. H. Mai, M. Suh and D. M. Proctor, Cancer Epidemiol., 2010, 34, 388–399 CrossRef CAS PubMed.
  50. C. Zhang, K. Cai, Q. Feng, Y. Xu and Z. Zhang, Toxicol. Lett., 2019, 300, 10–17 CrossRef CAS PubMed.
  51. J. C. Kouokam, R. M. Speer, I. Meaza, J. H. Toyoda, H. Lu and J. P. Wise, Toxicol. Appl. Pharmacol., 2024, 485, 116889 CrossRef CAS PubMed.
  52. J. Buters and T. Biedermann, J. Invest. Dermatol., 2017, 137, 274–277 CrossRef CAS PubMed.
  53. C. Wang, H. Shang, S. Zhang, X. Wang, D. Liu, M. Shen, N. Li, Y. Jiang, K. Wei and R. Zhu, Chem.-Biol. Interact., 2023, 379, 110523 CrossRef CAS PubMed.
  54. Y.-H. Wu, J.-C. Lin, T.-Y. Wang, T.-J. Lin, M.-C. Yen, Y.-H. Liu, P.-L. Wu, F.-W. Chen, Y.-L. Shih and I.-J. Yeh, Mol. Med. Rep., 2020, 21, 851–857 Search PubMed.
  55. R. P. Wedeen and L. F. Qian, Environ. Health Perspect., 1991, 92, 71–74 CAS.
  56. J. Yan, H. Huang, Z. Liu, J. Shen, J. Ni, J. Han, R. Wang, D. Lin, B. Hu and L. Jin, Toxicol. Lett., 2020, 320, 1–8 CrossRef CAS PubMed.
  57. S. Dutta, K. K. Sivakumar, J. W. Erwin, J. A. Stanley, J. A. Arosh, R. J. Taylor and S. K. Banu, Reprod. Toxicol., 2024, 123, 108492 CrossRef CAS PubMed.
  58. Q. Xue, L. Zhang, R. Wang, J. Xu, C. Wang, S. Gao, X. Fang, C. Meng, R. Lu and L. Guo, Toxicology, 2024, 508, 153908 CrossRef CAS PubMed.
  59. T. Li, Y. Zheng, Z. Wu, M. Guo, R. Liu, W. Zeng and Y. Lv, Toxicol. Lett., 2023, 377, 38–50 CrossRef CAS PubMed.
  60. F. A. Quinteros, A. H. B. Poliandri, L. I. Machiavelli, J. P. Cabilla and B. H. Duvilanski, Toxicol. Appl. Pharmacol., 2007, 218, 79–87 CrossRef CAS PubMed.
  61. S. T. Vielee, J. Isibor, W. J. Buchanan, S. H. Roof, M. Patel, I. Meaza, A. Williams, J. H. Toyoda, H. Lu, S. S. Wise, J. C. Kouokam, J. Young Wise, A.-M. Abouiessa, J. Cai, L. Cai and J. P. Wise, Toxicol. Appl. Pharmacol., 2024, 489, 117007 CrossRef CAS PubMed.
  62. A. Chiu, X. L. Shi, W. K. P. Lee, R. Hill, T. P. Wakeman, A. Katz, B. Xu, N. S. Dalal, J. D. Robertson, C. Chen, N. Chiu and L. Donehower, J. Environ. Sci. Health, Part C:Environ. Carcinog. Ecotoxicol. Rev., 2010, 28, 188–230 CrossRef CAS PubMed.
  63. P. H. Connett and K. E. Wetterhahn, Metabolism of the Carcinogen Chromate by Cellular Constituents, ed. P. H. Connett, H. Folłmann, M. Lammers, S. Mann, J. D. Odom and K. E. Wetterhahn, Springer Berlin Heidelberg, Berlin, Heidelberg, 1983, pp. 93–124,  DOI:10.1007/BFb0111319.
  64. K. W. Jennette, J. Am. Chem. Soc., 1982, 104, 874–875 CrossRef CAS.
  65. P. J. Jannetto, W. E. Antholine and C. R. Myers, Toxicology, 2001, 159, 119–133 CrossRef CAS PubMed.
  66. S. Valiente, C. Krawic and A. Zhitkovich, Toxicol. Appl. Pharmacol., 2023, 477, 116696 CrossRef CAS PubMed.
  67. A. Lalaouni, C. Henderson, C. Kupper and M. H. Grant, Toxicology, 2007, 236, 76–81 CrossRef CAS PubMed.
  68. J. Ning and M. H. Grant, Toxicol. In Vitro, 2000, 14, 329–335 CrossRef CAS PubMed.
  69. S.-C. Fu, J.-M. Liu, K.-I. Lee, F.-C. Tang, K.-M. Fang, C.-Y. Yang, C.-C. Su, H.-H. Chen, R.-J. Hsu and Y.-W. Chen, Toxicol. In Vitro, 2020, 65, 104795 CrossRef CAS PubMed.
  70. V. Velma and P. B. Tchounwou, Mutat. Res., Toxicol. Environ. Mutagen., 2010, 698, 43–51 CrossRef CAS PubMed.
  71. V. K. Raghunathan, E. M. Ellis and M. H. Grant, Toxicol. In Vitro, 2009, 23, 647–652 CrossRef CAS PubMed.
  72. F. A. Quinteros, L. I. Machiavelli, E. A. Miler, J. P. Cabilla and B. H. Duvilanski, Toxicology, 2008, 249, 109–115 CrossRef CAS PubMed.
  73. M. K. Ahmad, S. Syma and R. Mahmood, Biol. Trace Elem. Res., 2011, 144, 426–435 CrossRef CAS PubMed.
  74. X. L. Shi, A. Chiu, C. T. Chen, B. Halliwell, V. Castranova and V. Vallyathan, J. Toxicol. Environ. Health, Part B, 1999, 2(1), 87–104 CAS.
  75. X. Shi, Y. Mao, A. D. Knapton, M. Ding, Y. Rojanasakul, P. M. Gannett, N. Dalal and K. Liu, Carcinogenesis, 1994, 15, 2475–2478 CrossRef CAS PubMed.
  76. K. khorsandi and A. Rabbani-Chadegani, Mutat. Res., Toxicol. Environ. Mutagen., 2013, 750, 105–110 CrossRef CAS PubMed.
  77. F. Depault, M. Cojocaru, F. Fortin, S. Chakrabarti and N. Lemieux, Toxicol. In Vitro, 2006, 20, 513–518 CrossRef CAS PubMed.
  78. G. Hu, J. Liu, Y. Zhang, P. Zheng, L. Wang, L. Zhao, H. Xu, Z. Chen, T. Wang and G. Jia, Toxicol. Lett., 2016, 264, 71–78 CrossRef CAS PubMed.
  79. V. Balachandar, M. Arun, S. Mohana Devi, P. Velmurugan, P. Manikantan, A. Karthick Kumar, K. Sasikala and C. Venkatesan, Int. Arch. Occup. Environ. Health, 2010, 83, 791–801 CrossRef CAS PubMed.
  80. V. Gujar, H. Li, T. T. Paull, C. A. Neumann and U. Weyemi, Cell Rep., 2025, 44, 115540 CrossRef CAS PubMed.
  81. R. M. Speer, I. Meaza, J. H. Toyoda, Y. Lu, Q. Xu, R. B. Walter, M. Kong, H. Lu, J. C. Kouokam and J. P. Wise, Toxicol. Appl. Pharmacol., 2022, 438, 115890 CrossRef CAS PubMed.
  82. H. Lu, S. S. Wise, J. H. Toyoda, R. M. Speer, T. J. Croom-Perez, I. Meaza, J. C. Kouokam, J. L. Wise, G. Hoyle, N. Chen, J. P. Wise, K. Kondo, H. Toba, H. Takizawa and J. P. Wise, Chemosphere, 2025, 370, 143982 CrossRef CAS PubMed.
  83. S. Luo, C. Zhang, Z. Gao, L. Jiang, Q. Li, X. Shi, Y. Kong and J. Cao, Chem.-Biol. Interact., 2023, 369, 110293 CrossRef CAS PubMed.
  84. X. Zheng, Y. Pang, Hasenbilige, Y. Yang, Q. Li, Y. Liu and J. Cao, Ecotoxicol. Environ. Saf., 2024, 281, 116639 CrossRef CAS PubMed.
  85. G. Hu, T. Wang, J. Liu, Z. Chen, L. Zhong, S. Yu, Z. Zhao, M. Zhai and G. Jia, Toxicol. Lett., 2017, 277, 76–83 CrossRef CAS PubMed.
  86. Y. Zhao, J. Yan, A.-P. Li, Z.-L. Zhang, Z.-R. Li, K.-J. Guo, K.-C. Zhao, Q. Ruan and L. Guo, Toxicol. Lett., 2019, 310, 31–38 CrossRef CAS PubMed.
  87. A. Moonwiriyakit, S. Dinsuwannakol, J. Sontikun, K. Timpratueang, C. Muanprasat and P. Khemawoot, Environ. Toxicol. Pharmacol., 2024, 107, 104416 CrossRef CAS PubMed.
  88. I. Franchini and A. Mutti, Sci. Total Environ., 1988, 71, 379–387 CrossRef CAS PubMed.
  89. S. S. Wise and J. P. Wise, Mutat. Res. Fund Mol. Mech. Mutagen, 2012, 733, 78–82 CrossRef CAS PubMed.
  90. N. S. Raja and B. U. Nair, Toxicology, 2008, 251, 61–65 CrossRef CAS PubMed.
  91. K. Balamurugan, R. Rajaram, T. Ramasami and S. Narayanan, Free Radic. Biol. Med., 2002, 33, 1622–1640 CrossRef CAS PubMed.
  92. R. Y. S. Cheng, W. Gregory Alvord, D. Powell, K. S. Kasprzak and L. M. Anderson, Reprod. Toxicol., 2002, 16, 223–236 CrossRef CAS PubMed.
  93. WHO, Health Criteria and Other Supporting Information, Guidelines for Drinking-Water Quality, World Health Organization, Geneva, 2nd edn, 1996, vol. 2 Search PubMed.
  94. Bureau of Indian Standards, IS 10500 : 2012 - Drinking Water — Specification (Second Revision).
  95. 2018 Edition of the Drinking Water Standards and Health Advisories (Report No. EPA 822-F-18-001), U.S. Environmental Protection Agency Search PubMed.
  96. Occupational Safety and Health Administration, United States Department of Labor, Hexavalent Chromium (Publication No. OSHA 3373-10, 2009), 2009, p. 28 Search PubMed.
  97. C. M. Thompson, C. Kirman and M. A. Harris, Regul. Toxicol. Pharmacol., 2023, 145, 105521 CrossRef CAS PubMed.
  98. C. M. Thompson, A. Bichteler, J. E. Rager, M. Suh, D. M. Proctor, L. C. Haws and M. A. Harris, Mutat. Res., Toxicol. Environ. Mutagen., 2016, 800–801, 28–34 CrossRef CAS PubMed.
  99. D. M. Proctor, M. Suh, S. L. Campleman and C. M. Thompson, Toxicology, 2014, 325, 160–179 CrossRef CAS PubMed.
  100. D. M. Proctor, V. Bhat, M. Suh, H. Reichert, X. Jiang and C. M. Thompson, Regul. Toxicol. Pharmacol., 2021, 124, 104969 CrossRef CAS PubMed.
  101. M. Figgitt, R. Newson, I. J. Leslie, J. Fisher, E. Ingham and C. P. Case, Mutat. Res. Fund Mol. Mech. Mutagen, 2010, 688, 53–61 CrossRef CAS PubMed.
  102. R. V Badhe, O. Akinfosile, D. Bijukumar, M. Barba and M. T. Mathew, Toxicol. Lett., 2021, 350, 213–224 CrossRef PubMed.
  103. N. Ekweariri, R. White, N. Brown and D. Schmitt, Knee, 2024, 48, 46–51 CrossRef PubMed.
  104. D. J. Mazur-Hart, E. W. Larson, N. K. Yaghi, A. M. Halfpenny, D. R. Pettersson and D. A. Yam, Radiol. Case Rep., 2022, 17, 1540–1548 CrossRef PubMed.
  105. F. Mohsin, M. B. A. Zubairi, K. Fatima and M. A. Diwan, Radiol. Case Rep., 2023, 18, 1311–1315 CrossRef PubMed.
  106. R. Fukuda, M. Matsuoka, T. Onodera, K. Iwasaki, D. Tanaka, H. Hiraga, H. Kanno-Okada, Y. Matsuno, E. Kondo and N. Iwasaki, Knee, 2021, 28, 151–158 CrossRef PubMed.
  107. D. Sherson, N. Maltbaek and K. Heydorn, Eur. Respir. J., 1990, 3, 1227–1229 CrossRef CAS PubMed.
  108. E. Leese, K. Jones, B. Bocca, R. Bousoumah, A. Castaño, K. S. Galea, I. Iavicoli, M. E. López, V. Leso, S. Ndaw, S. P. Porras, F. Ruggieri, P. T. J. Scheepers, T. Santonen, R. Anzion, A. Cattaneo, D. M. Cavallo, G. De Palma, G. Forte, R. Lehtinen, P. Lovreglio, M. Melczer, M. Senofonte, S. Spankie and M. van Dael, Toxicol. Lett., 2023, 375, 59–68 CrossRef CAS PubMed.
  109. S. Guo, C. Yu, X. Zhao, Y. chen, J. Wang, M. Su, X. Yang and J. Yang, J. Cleaner Prod., 2022, 374, 133776 CrossRef CAS.
  110. F. Kurniasari, A. Tazaki, K. Hashimoto, T. Yuan, M. M. A. Al Hossain, A. A. Akhand, N. Ahsan, S. Ohnuma and M. Kato, Chemosphere, 2022, 303, 135098 CrossRef CAS PubMed.
  111. A. K. Tiwari, S. Orioli and M. De Maio, J. Contam. Hydrol., 2019, 225, 103503 CrossRef CAS PubMed.
  112. F. Botsou, E. Louropoulou, T. Elias, E. Aidona, M. Dassenakis, M. Scoullos and A. P. Karageorgis, Appl. Geochem., 2024, 167, 105997 CrossRef CAS.
  113. P. K. Gupta, V. K. Nair, V. Dalvi, S. Dhali, A. Malik and K. K. Pant, J. Hazard. Mater., 2024, 467, 133747 CrossRef CAS PubMed.
  114. A. Villalobos-Aragón, A. S. Ellis, M. A. Armienta, O. Morton-Bermea and T. M. Johnson, Appl. Geochem., 2012, 27, 1783–1794 CrossRef.
  115. I. Panagiotakis, D. Dermatas, C. Vatseris, M. Chrysochoou, N. Papassiopi, A. Xenidis and K. Vaxevanidou, J. Hazard. Mater., 2015, 281, 27–34 CrossRef CAS PubMed.
  116. M. Ben Ali, H. El Fadili, M. El Mahi, E. M. Lotfi, A. Fannakh and A. Chahine, Environ. Nanotechnol., Monit. Manage., 2023, 20, 100859 CAS.
  117. Q. He, Y. He, Z. Zhang, G. Ou, K. Zhu, W. Lou, K. Zhang, Y. Chen and W. Ye, Chemosphere, 2023, 340, 139897 CrossRef CAS PubMed.
  118. N. Kazakis, N. Kantiranis, K. Kalaitzidou, E. Kaprara, M. Mitrakas, R. Frei, G. Vargemezis, P. Tsourlos, A. Zouboulis and A. Filippidis, Sci. Total Environ., 2017, 593–594, 552–566 CrossRef CAS PubMed.
  119. X. Wang, L. Li, X. Yan, X. Meng and Y. Chen, Chemosphere, 2020, 257, 127282 CrossRef CAS PubMed.
  120. J. Vethanayaham, E. C. Partheeban, P. Kolandhasamy, V. Dharmaraj, R. Rajendran and P. Sadayan, Total Environ. Adv., 2024, 11, 200106 CrossRef.
  121. M. Novak, O. Sebek, V. Chrastny, L. A. Hellerich, A. Andronikov, E. Martinkova, J. Farkas, P. Pacherova, J. Curik, M. Stepanova, E. Prechova, M. Houskova, V. Zoulkova, F. Veselovsky, I. Svobodova, P. Janotova and A. Komarek, Chem. Geol., 2018, 481, 74–84 CrossRef CAS.
  122. C. T. Mills, J. M. Morrison, M. B. Goldhaber and K. J. Ellefsen, Appl. Geochem., 2011, 26, 1488–1501 CrossRef CAS.
  123. S. M. Equeenuddin and B. K. Pattnaik, Geochemistry, 2020, 80, 125633 CrossRef CAS.
  124. S.-S. Sun, M. Ao, K.-R. Geng, J.-Q. Chen, T.-H.-B. Deng, J.-J. Li, Z.-T. Guan, B.-L. Mo, T. Liu, W.-J. Yang, Y.-T. Tang and R.-L. Qiu, Sci. Total Environ., 2022, 822, 153304 CrossRef CAS PubMed.
  125. N. Kazakis, N. Kantiranis, K. S. Voudouris, M. Mitrakas, E. Kaprara and A. Pavlou, Sci. Total Environ., 2015, 514, 224–238 CrossRef CAS PubMed.
  126. G. Thery, F. Juillot, D. Calmels, Q. Bollaert, M. Meyer, T. Quiniou, M. David, P. Jourand, M. Ducousso, E. Fritsch, G. Landrot, G. Morin and C. Quantin, Sci. Total Environ., 2024, 922, 171037 CrossRef CAS PubMed.
  127. C. Liu, H. Guo, W. Fan, R. Xu, S. Han, B. Gao, B. Zhao and C. Jiang, Sci. Total Environ., 2023, 893, 164890 CrossRef CAS PubMed.
  128. M. Perraki, E. Vasileiou and G. Bartzas, Curr. Opin. Environ. Sci. Health, 2021, 22, 100267 CrossRef.
  129. J. A. Izbicki, M. T. Wright, W. A. Seymour, R. B. McCleskey, M. S. Fram, K. Belitz and B. K. Esser, Appl. Geochem., 2015, 63, 203–217 CrossRef CAS.
  130. R. Ying, B. Yang, M. Chen, X. Zhang, C. Zhao, T. Long, H. Qiu and W. Ji, J. Hazard. Mater., 2024, 471, 134414 CrossRef CAS PubMed.
  131. Y. Li, S. Hu, X. Cui, X. Tian, X. Zhang, S. Cao and Y. Fei, Desalin. Water Treat., 2019, 150, 114–123 CrossRef CAS.
  132. Y. He, G. Ou, Z. Zhang, Z. Shen, H. Wei, X. Ding, Q. Wang, K. Zhang, Y. Chen and W. Ye, J. Hazard. Mater., 2024, 479, 135662 CrossRef CAS PubMed.
  133. R. E. Delina, C. Arcilla, T. Otake, J. J. Garcia, M. Tan and A. Ito, Chem. Geol., 2020, 558, 119863 CrossRef CAS.
  134. P. Longmire, M. Dale and K. Granzow, Procedia Earth Planet. Sci., 2013, 7, 517–520 CrossRef CAS.
  135. M. A. Lilli, E. Syranidou, A. Palliou, N. P. Nikolaidis, G. Karatzas and N. Kalogerakis, Environ. Res., 2017, 152, 96–101 CrossRef CAS PubMed.
  136. H. Guo, C. Liu, S. Yan, J. Yin and J. Shan, J. Hydrol., 2024, 638, 131480 CrossRef CAS.
  137. M. Chrysochoou, E. Theologou, N. Bompoti, D. Dermatas and I. Panagiotakis, Curr. Pollut. Rep., 2016, 2, 224–235 CrossRef CAS.
  138. J. Liang, X. Huang, J. Yan, Y. Li, Z. Zhao, Y. Liu, J. Ye and Y. Wei, Sci. Total Environ., 2021, 774, 145762 CrossRef CAS.
  139. M. Ao, S. Sun, T. Deng, F. Zhang, T. Liu, Y. Tang, J. Li, S. Wang and R. Qiu, J. Hazard. Mater., 2022, 433, 128805 CrossRef CAS PubMed.
  140. C. Apollaro, I. Fuoco, G. Brozzo and R. De Rosa, Sci. Total Environ., 2019, 660, 1459–1471 CrossRef CAS PubMed.
  141. X. Liu, H. Dong and C. M. Hansel, Environ. Sci. Technol., 2021, 55, 16236–16245 CrossRef CAS PubMed.
  142. J. Ning, P. Li, X. He, V. Elumalai, M. Fida, D. Xu and P. Zhang, Environ. Pollut., 2025, 367, 125654 CrossRef CAS PubMed.
  143. F. Botsou, E. Koutsopoulou, A. Andrioti, M. Dassenakis, M. Scoullos and A. P. Karageorgis, Environ. Geochem. Health, 2022, 44, 2815–2834 CrossRef CAS PubMed.
  144. K. Nakagawa, T. Hosokawa, S.-I. Wada, K. Momii, K. Jinno and R. Berndtsson, Hydrol. Processes, 2010, 24, 608–617 CrossRef CAS.
  145. S. Yan, H. Guo, J. Yin, H. Hu, D. Cui and B. Gao, Water Res., 2022, 216, 118323 CrossRef CAS PubMed.
  146. M. Novak, E. Martinkova, V. Chrastny, M. Stepanova, O. Sebek, A. Andronikov, J. Curik, F. Veselovsky, E. Prechova, M. Houskova, F. Buzek, J. Farkas and A. Komarek, Catena, 2017, 158, 371–380 CrossRef CAS.
  147. E. K. Adotey, L. Burkutova, L. Tastanova, A. Bekeshev, M. P. Balanay, S. Sabanov, A. M. Rule, P. K. Hopke and M. Amouei Torkmahalleh, Chemosphere, 2022, 307, 136057 CrossRef CAS PubMed.
  148. F. Kurniasari, M. T. Htike, A. Tazaki, T. Kagawa, M. M. A. Al Hossain, A. A. Akhand, N. Ahsan, S. Ohnuma, N. Iwasaki and M. Kato, Chemosphere, 2024, 350, 141047 CrossRef CAS PubMed.
  149. X. Li, C. Yan, C. Wang, J. Ma, W. Li, J. Liu and Y. Liu, Sci. Total Environ., 2022, 806, 150440 CrossRef CAS PubMed.
  150. F. Sannoh, Z. Fatmi, D. O. Carpenter, M. Santoso, A. Siddique, K. Khan, J. Zeb, M. M. Hussain and H. A. Khwaja, Sci. Total Environ., 2024, 942, 173403 CrossRef CAS PubMed.
  151. Q. He, C. Li and J. Zhang, Spectrochim. Acta, Part B, 2023, 206, 106728 CrossRef CAS.
  152. W.-S. Zhong, T. Ren and L.-J. Zhao, J. Food Drug Anal., 2016, 24, 46–55 CrossRef CAS PubMed.
  153. M. C. Bruzzoniti, T. Schilirò, M. Gea and L. Rivoira, Environ. Res., 2024, 242, 117731 CrossRef CAS PubMed.
  154. R. Raja, D. Jyoti Sarkar, A. Biswas, S. Mondal, V. Kumar Aralappanavar, J. Dei, B. Kumar Behera, S. Bhattacharyya, S. Pal, S. Mukherjee and B. Kumar Das, Spectrochim. Acta, Part A, 2025, 324, 124967 CrossRef CAS PubMed.
  155. S. Sudan, J. Kaushal, T. G. Singh, M. H. Mahmoud, A. Alexiou, M. Papadakis, M. E. A.-E. Fetoh and G. E.-S. Batiha, Microchim. Acta, 2025, 192, 88 CrossRef CAS PubMed.
  156. G. Huang, H. Ye, X. Mo, R. Hao, G. Huang, J. Liang, D. Wang, X. Xiao and W. Zhu, Anal. Methods, 2024, 16, 7161–7168 RSC.
  157. C. Ichsan and S. Rodiah, J. Iran. Chem. Soc., 2024, 21, 2335–2349 CrossRef CAS.
  158. M. Ben Jaballah, A. Karrat, A. Amine and C. Dridi, Talanta, 2023, 265, 124889 CrossRef CAS PubMed.
  159. Z. Arif, S. Sugiarti, E. Rohaeti and I. Batubara, Pure Appl. Chem., 2025 DOI:10.1515/pac-2024-0348.
  160. B. Ghanbari, P. Zamani and J. Janczak, Inorg. Chem. Commun., 2025, 178(Part 2), 114568 CrossRef CAS.
  161. Y. Chen, Z. Wang, M. Liang, Y. Liu, W. Dong, Q. Hu, C. Dong and X. Gong, Int. J. Biol. Macromol., 2024, 274(Part 2), 133790 CrossRef CAS PubMed.
  162. Y. Jia, S. Wu, Z. Duan, S. Song, S. Shuang, X. Gong and C. Dong, Spectrochim. Acta, Part A, 2022, 278, 121343 CrossRef CAS PubMed.
  163. C.-X. Yao, L. Yang, J. Wang, H. Lv, X.-M. Ji, S.-J. Li, J.-M. Liu and S. Wang, Microchim. Acta, 2022, 189(9), 354 CrossRef CAS PubMed.
  164. J. Hu, B. Li, M. Su, C. Jing, S. Liu, G. Niu and B. Wang, Colloids Surf., A, 2025, 705(Part 1), 135565 CrossRef CAS.
  165. H. Fang, J.-P. Han, B. Zhang, D.-B. Liu, X.-W. Li, J.-Y. Li, Y. He and M.-H. Yu, CrystEngComm, 2025, 27, 1139–1145 RSC.
  166. F. Wang, Y. Wang, Z. Xie, Z. Zhao, Z. Dong, X. Feng, Q. Ren and C. Dong, Appl. Organomet. Chem., 2024, 38(11), e7673 CrossRef CAS.
  167. B. Li, Q. Lei, F. Wang, D. Zhao, Y. Deng, L. Yang, L. Fan and Z. Zhang, J. Solid State Chem., 2021, 298, 122117 CrossRef CAS.
  168. D.-M. Chen, H.-D. Qiao and S.-M. Fang, J. Rare Earths, 2025, 43, 1026–1034 CrossRef CAS.
  169. G. Yuan, C. Zhang, Y.-Y. Sun, X.-M. Li, X.-H. Yu and Z.-M. Su, Inorg. Chem. Commun., 2024, 169, 113066 CrossRef CAS.
  170. F.-H. Zhao, R. Feng, S.-Q. Li, J.-J. Zhang, W.-C. Yu and Z.-L. Li, Cryst. Growth Des., 2024, 24, 5335–5348 CrossRef CAS.
  171. S. Jiang, Z. Yan, Y. Deng, W. Deng, H. Xiao and W. Wu, Int. J. Biol. Macromol., 2024, 262(Part 1), 129854 CrossRef CAS PubMed.
  172. M. Ochoa-Pérez, J. Juárez-Gómez, S. Meneses-Aparicio, D. S. Guzmán-Hernández, V. Lara, A. Rojas-Hernández and M. T. Ramírez-Silva, Sens. Acutators Rep., 2024, 8, 100226 Search PubMed.
  173. R. A. Sánchez-Moreno, M. J. Gismera, M. T. Sevilla and J. R. Procopio, Sens. Actuators, B, 2010, 143, 716–723 CrossRef.
  174. A. Zazoua, K. Morakchi, R. Kherrat, M. H. Samar, A. Errachid, N. Jaffrezic-Renault and R. Boubellout, ITBM-RBM, 2008, 29, 187–191 Search PubMed.
  175. P. Kurup, C. Sullivan, M. Morrisey and S. Dutta, in A Novel Sensor System for Rapid Onsite Detection of Groundwater Contaminants, Geotechnical Special Publication, 2025, pp. 147–156,  DOI:10.1061/9780784485682.017.
  176. C. Wang and C. K. Chan, ECS J. Solid State Sci. Technol., 2016, 5, M3026–M3031 CrossRef CAS.
  177. J. Dei, S. Bhattacharyya, K. Ghosh, S. Sarkar, S. Pal, S. Mukherjee, D. J. Sarkar, A. Ghosh, R. Bandyopadhyay, B. K. Das and B. K. Behera, Curr. Res. Biotechnol., 2024, 7, 100193 CrossRef CAS.
  178. S. Chen, R. Li, Y. Wang, Q. Hu and X. Chen, ECS J. Solid State Sci. Technol., 2025, 14(4), 047003 CrossRef CAS.
  179. Z.-J. Ding, Y. Liu, R. Weerasooriya and X. Chen, Anal. Lett., 2024, 57, 753–771 CrossRef CAS.
  180. H. Zhang, K. Deng, X. Qian, C. Li, J. Wang, Q. Yi, H. Huang and H. Zhou, Microchem. J., 2023, 194, 109356 CrossRef CAS.
  181. Y. Li, J. Zhang, S. Shang, F. Wang, H. Mei and H. Wu, J. Alloys Compd., 2023, 965, 171511 CrossRef CAS.
  182. Y. Zhang, J. Shan, L. Zhang, S. Zhou, X. Yang and J. Liao, Sens. Actuators, B, 2023, 396, 134563 CrossRef CAS.
  183. R. Siavash Moakhar, G. K. L. Goh, A. Dolati and M. Ghorbani, Appl. Catal., B, 2017, 201, 411–418 CrossRef CAS.
  184. R. Siavash Moakhar, G. K. L. Goh, A. Dolati and M. Ghorbani, Electrochem. Commun., 2015, 61, 110–113 CrossRef CAS.
  185. A. Muhammed, A. Hussen and T. Kaneta, Anal. Sci., 2024, 40, 709–717 CrossRef CAS PubMed.
  186. X. Li, C. Chen and H. Chang, in Proceedings of the IEEE International Conference on Micro Electro Mechanical Systems (MEMS), 2018, pp. 1157–1160 Search PubMed.
  187. W. Alahmad, P. Varanusupakul, T. Kaneta and P. Varanusupakul, Anal. Chim. Acta, 2019, 1085, 98–106 CrossRef CAS PubMed.
  188. F. Liendo, B. Pichún, A. P. D. L. Vega, J. Penagos, N. Serrano, J. M. Díaz-Cruz, J. Pizarro, R. Segura and M. J. Aguirre, Nanomaterials, 2024, 14(17), 1465 CrossRef CAS PubMed.
  189. L. Guo, Y. Shi, K.-W. Li, J. Yan, Z.-N. Hong, J. Jiang and R.-K. Xu, Ecotoxicol. Environ. Saf., 2024, 273, 116117 CrossRef CAS PubMed.
  190. M. Li, Y. Tang, R. Zhao, T. Gao and L. Zhang, J. Hazard. Mater., 2022, 433, 128809 CrossRef CAS PubMed.
  191. D. V Franco, M. L. K. Rodrigues, J. Bavaresco and W. F. Jardim, Quim. Nova, 2011, 34, 1255–1259 CrossRef.
  192. M. Fotouhi, S. Seidi, B. Nasihatkon, S. Solouki and N. Rezaei, J. Environ. Chem. Eng., 2024, 12(1), 111763 CrossRef CAS.
  193. J. Zhu, H. Yin, S. Zheng, H. Yu, L. Yang, L. Wang, X. Geng and Y. Deng, J. Sci. Food Agric., 2024, 104, 8008–8021 CrossRef CAS PubMed.
  194. L. Zhao, W. Wang, Y. Wang, H. Li, L. Zhao, N. Wang, Y. Wang, X. Wang and Q. Pu, J. Hazard. Mater., 2021, 417, 125986 CrossRef CAS PubMed.
  195. J. Soni, H. Upadhyay, L. Lagos, M. Siddiquee and X. Song, Water, 2025, 17(1), 121 CrossRef CAS.
  196. S. D. Bamane, V. Bhojwani, P. L. Balkunde, M. Bhattacharya, I. Gupta, A. K. Mohapatra, A. Shekhar and A. Singh, Anal. Bioanal. Chem., 2021, 413, 3455–3469 CrossRef CAS PubMed.
  197. R. Brito-Pereira, J. M. Queirós, L. Celaya-Azcoaga, R. F. de Luiz, P. Martins and S. Lanceros-Mendez, J. Environ. Chem. Eng., 2024, 12(5), 113839 CrossRef CAS.
  198. M. Zhou, M. Chen, Y. Wang, C. Mao, Y. Zhang, J. Liu, X. Zhang, S. Pang and X. Yang, Int. J. Biol. Macromol., 2025, 294, 139466 CrossRef CAS PubMed.
  199. J. Lu, K. Xu, J. Yang, Y. Hao and F. Cheng, Carbohydr. Polym., 2017, 173, 28–36 CrossRef CAS PubMed.
  200. O. Sentse, T. Xaba, N. D. Shooto, V. E. Pakade and W. Omwoyo, Inorg. Chem. Commun., 2024, 159, 111755 CrossRef CAS.
  201. L. Wang, Y. Zhu, L. Ma, X. Hai, X. Li, Z. Yang, Y. Gao, M. Yuan, H. Xiong, M. Chen and X. Ma, Chemosphere, 2024, 362, 142732 CrossRef CAS PubMed.
  202. J. Jimenez-Paz, J. J. Lozada-Castro, E. Lester, O. Williams, L. Stevens and J. Barraza-Burgos, J. Environ. Chem. Eng., 2023, 11, 109715 CrossRef CAS.
  203. M. Masuku, J. F. Nure, H. I. Atagana, N. Hlongwa and T. T. I. Nkambule, Sci. Total Environ., 2024, 908, 168136 CrossRef CAS PubMed.
  204. Y. H. Fseha, J. O. Eniola, B. Sizirici, S. Stephen, I. Yildiz, A. Khaleel and A. Adamson, Sustainable Chem. Environ., 2024, 7, 100127 CrossRef.
  205. P. Ray, M. A. Sabri, T. H. Ibrahim, M. I. Khamis and F. H. Jumean, Desalin. Water Treat., 2018, 113, 109–113 CrossRef CAS.
  206. G. Moussavi and S. Talebi, Chem. Eng. Res. Des., 2012, 90, 960–966 CrossRef CAS.
  207. M. M. Kabir, M. M. Akter, S. Khandaker, B. H. Gilroyed, M. Didar-ul-Alam, M. Hakim and M. R. Awual, J. Mol. Liq., 2022, 347, 118327 CrossRef CAS.
  208. M. Gueye, Y. Richardson, F. T. Kafack and J. Blin, J. Environ. Chem. Eng., 2014, 2, 273–281 CrossRef CAS.
  209. Y. Cai, J. Yang, Z. Ran, F. Bu, X. Chen, M. Shaaban and Q. Peng, Chemosphere, 2024, 354, 141739 CrossRef CAS PubMed.
  210. N. D. Shooto, J. Environ. Chem. Eng., 2020, 8, 104541 CrossRef CAS.
  211. R. Mittal, S. Patar, A. Sharma, R. Bhateria, A. Kumar Bhardwaj, R. Kashyap and S. Bhukal, Appl. Surf. Sci., 2025, 679, 161309 CrossRef CAS.
  212. C. Ma, D. Liu, S. Deng and M. Vakili, Chem. Eng. Res. Des., 2024, 204, 664–672 CrossRef CAS.
  213. C. Niu, N. Zhang, C. Hu, C. Zhang, H. Zhang and Y. Xing, Carbohydr. Polym., 2021, 258, 117644 CrossRef CAS PubMed.
  214. J. Chen, Y. Qiu, X. Liu and L. Guo, Appl. Surf. Sci., 2024, 652, 159278 CrossRef CAS.
  215. M. Shakiba, M. Abdouss, S. Mazinani, M. Kalaee and R. E. Neisiany, J. Environ. Chem. Eng., 2025, 13, 115728 CrossRef CAS.
  216. M. Salehi, M. Shakiba, S. Mazinani, M. Abdouss and M. Kalaee, J. Water Process Eng., 2025, 69, 106683 CrossRef.
  217. Q. Zhou, C. Yan and W. Luo, Mater. Des., 2016, 92, 701–709 CrossRef CAS.
  218. A. Anjum, S. A. Mazari, Z. Hashmi, A. S. Jatoi, R. Abro, A. W. Bhutto, N. M. Mubarak, M. H. Dehghani, R. R. Karri, A. H. Mahvi and S. Nasseri, Heliyon, 2023, 9, e15575 CrossRef CAS PubMed.
  219. M. A. Hashem, M. A. Momen, M. Hasan, M. S. Nur-A-Tomal and M. H. R. Sheikh, Int. J. Environ. Sci. Technol., 2019, 16, 1395–1404 CrossRef CAS.
  220. Y. Ma, W.-J. Liu, N. Zhang, Y.-S. Li, H. Jiang and G.-P. Sheng, Bioresour. Technol., 2014, 169, 403–408 CrossRef CAS PubMed.
  221. M. Akram, H. N. Bhatti, M. Iqbal, S. Noreen and S. Sadaf, J. Environ. Chem. Eng., 2017, 5, 400–411 CrossRef CAS.
  222. Y. Zhao, M. Kunieda, N. Obi and S. Watanabe, Precis. Eng., 2017, 49, 211–219 CrossRef.
  223. Y. Yin, C. Shen, X. Bi and T. Li, Sci. Rep., 2020, 10, 12137 CrossRef CAS PubMed.
  224. A. L. Mungan, E. A. Hjelvik, A. P. Straub and J. A. Korak, Environ. Sci.: Adv., 2024, 3, 1598–1615 CAS.
  225. M. Gheju and I. Balcu, J. Hazard. Mater., 2011, 196, 131–138 CrossRef CAS PubMed.
  226. R.-F. Yu, F.-H. Chi, W.-P. Cheng and J.-C. Chang, Chem. Eng. J., 2014, 255, 568–576 CrossRef CAS.
  227. L.-Y. Chang, Environ. Prog., 2003, 22, 174–182 CrossRef CAS.
  228. Y. Ban, Z. Wan, C. Ma, Y. Wu and H. Chen, Chem. Eng. Sci., 2025, 309, 121518 CrossRef CAS.
  229. H. Wei, Y. He, L. Peng, Z. Zhang, W. Lou, K. Zhu and K. Zhang, J. Water Process Eng., 2024, 68, 106465 CrossRef.
  230. S. Golbaz, A. J. Jafari and R. R. Kalantari, Desalin. Water Treat., 2013, 51, 5761–5767 CrossRef CAS.
  231. Y. Ait Ouaissa, M. Chabani, A. Amrane and A. Bensmaili, Chem. Eng. Technol., 2013, 36, 147–155 CrossRef CAS.
  232. R. T. Doumbi, J. O. Kowe, Domga, D. weldi Gnowe and G. B. Noumi, Clean Water, 2024, 2, 100032 CrossRef.
  233. N. Chen, X. Cui, X. Sun, X. Yang, W. Yang, N. Ren, Y. Feng, Y. Tian and W. He, J. Water Process Eng., 2024, 63, 105445 CrossRef.
  234. S. Aoudj, B. Cheknane, H. Zemmouri, F. Zermane, A. Khelifa, M. Hecini and N. Drouiche, Desalin. Water Treat., 2017, 82, 262–270 CrossRef CAS.
  235. I. Frenzel, H. Holdik, V. Barmashenko, D. F. Stamatialis and M. Wessling, J. Appl. Electrochem., 2006, 36, 323–332 CrossRef CAS.
  236. J. Wan, M. Yu, W. Bi, Y. Sun, W. Wang, Y. Hou, S. Xie, T. Li and Y. Fan, J. Water Process Eng., 2024, 68, 106447 CrossRef.
  237. Y.-U. Shin, W. Pan, S. K. Patel, J. Lim, L. R. Winter, W. Ma, S. Hong and M. Elimelech, Chem. Eng. J., 2023, 474, 145756 CrossRef CAS.
  238. D. Yang, L. Wang, Y. Li, W. Song, X. Li, T. Yan and L. Yan, Sep. Purif. Technol., 2024, 328, 125004 CrossRef CAS.
  239. S. Dahiya, A. Singh, A. Tripathi and B. K. Mishra, J. Water Process Eng., 2025, 69, 106864 CrossRef.
  240. P. Sane, S. Chaudhari, P. Nemade and S. Sontakke, J. Environ. Chem. Eng., 2018, 6, 68–73 CrossRef CAS.
  241. X. Feng, J. Shang and J. Chen, Mol. Catal., 2017, 427, 11–17 CrossRef CAS.
  242. A. Fattah-alhosseini, Z. Sangarimotlagh, B. Dikici and M. Kaseem, J. Alloys Compd., 2025, 1015, 178846 CrossRef CAS.
  243. A. Chakravorty and S. Roy, Sustainable Chem. Environ., 2024, 8, 100155 CrossRef.
  244. H.-T. Hsu, S.-S. Chen and Y.-S. Chen, Sep. Purif. Technol., 2011, 80, 663–669 CrossRef CAS.
  245. L. Gan, A. Geng, C. Song, L. Xu, L. Wang, X. Fang, S. Han, J. Cui and C. Mei, Environ. Res., 2020, 185, 109414 CrossRef CAS PubMed.
  246. A. Chakravorty and S. Roy, Sustainable Chem. Environ., 2024, 8, 100155 CrossRef.
  247. L. Liu, A. He and X. Yao, Int. J. Electrochem. Sci., 2022, 17, 220635 CrossRef CAS.
  248. Q. Gao, M. Wang, Y. Zhu, Y. Chai and B. Liu, Appl. Surf. Sci., 2025, 693, 162789 CrossRef CAS.
  249. M. Lan, X. Dong, N. Zheng and Y. Liu, Mol. Catal., 2025, 579, 115023 CrossRef CAS.
  250. L. Han, D. Mao, Y. Huang, L. Zheng, Y. Yuan, Y. Su, S. Sun and D. Fang, J. Cleaner Prod., 2017, 168, 519–525 CrossRef CAS.
  251. V. A. Naik and V. A. Thakur, Inorg. Chem. Commun., 2024, 160, 111962 CrossRef CAS.
  252. Q. Jin, G. Xie, X. Cai, X. Hu, H. Wang, G. Qiu, W. Wang, D. Zhou, H. Huo, X. Tan and Y. Zhao, RSC Adv., 2020, 10, 6121–6128 RSC.
  253. L. Chen, H. Yuan, H. Zhao and B. Li, Inorg. Chem. Commun., 2025, 174, 114099 CrossRef CAS.
  254. F. P. Andrew, T. R. Papo and P. A. Ajibade, Environ. Adv., 2024, 17, 100575 CrossRef CAS.
  255. Y. Benmansour, M. A. Didi and O. Abderarhim, Desalin. Water Treat., 2022, 249, 281–296 CrossRef CAS.
  256. Y. Benmansour, M. A. Didi and O. Abderarhim, Desalin. Water Treat., 2022, 249, 281–296 CrossRef CAS.
  257. A. Nam, U. S. Choi, S.-T. Yun, J.-W. Choi, J.-A. Park and S.-H. Lee, J. Ind. Eng. Chem., 2018, 66, 187–195 CrossRef CAS.
  258. K. Xiao, F. Xu, L. Jiang, N. Duan and S. Zheng, Chem. Eng. J., 2016, 283, 1349–1356 CrossRef CAS.
  259. J. Leonard, S. Sivalingam, R. V. Srinadh and S. Mishra, Environ. Chem. Ecotoxicol., 2023, 5, 98–107 CrossRef CAS.
  260. P. Thiripelu, J. Manjunathan, M. Revathi and P. Ramasamy, J. Water Process Eng., 2024, 58, 104815 CrossRef.
  261. B. F. Jirjis and S. Luque, Practical Aspects of Membrane System Design in Food and Bioprocessing Applications, Membrane Technology, ed. Z. F. Cui and H. S. B. T.-M. T. Muralidhara, Butterworth-Heinemann, Oxford, 2010, ch. 9, pp. 179–212,  DOI:10.1016/B978-1-85617-632-3.00009-4.
  262. J. Cai, B. Liu, F. Xie, X. Mao and B. Zhang, J. Water Process Eng., 2025, 69, 106631 CrossRef.
  263. S. A. Rad, S. A. Mirbagheri and T. Mohammadi, World Acad. Sci. Eng. Technol., 2009, 57, 348–352 Search PubMed.
  264. S. A. Rad, S. A. Mirbagheri and T. Mohammadi, World Acad. Sci. Eng. Technol., 2009, 57, 348–352 Search PubMed.
  265. C. S. L. dos Santos, M. H. Miranda Reis, V. L. Cardoso and M. M. de Resende, J. Environ. Chem. Eng., 2019, 7, 103380 CrossRef.
  266. A. S. Dharnaik and P. K. Ghosh, Environ. Technol., 2014, 35, 2272–2279 CrossRef CAS PubMed.
  267. M. Tan, S. Yang, C. Song, Z. He, J. Wang, Y. Liu, F. Liu and Y. Zhang, Chem. Eng. J., 2024, 499, 156182 CrossRef CAS.
  268. Y. Raharjo, R. Ramadhan, J. Nathanael, M. I. Nugroho, A. J. T. Fetty and A. F. Ismail, RSC Adv., 2025, 15, 7149–7159 RSC.
  269. D. Shen, H. Ma, M. Khan and B. S. Hsiao, Chem. Eng. J., 2024, 479, 147269 CrossRef CAS.
  270. S. Divakar, H. G. Sampatkumar, S. S. Naik, S. Malladi, M. Padaki, S. A. Patil and R. G. Balakrishna, Sep. Purif. Technol., 2024, 334, 125953 CrossRef CAS.
  271. A. M. Mohammed, M. R. Thalji, S. A. Yasin, J.-J. Shim, K. F. Chong, A. A. Guda and G. A. M. Ali, J. Mol. Liq., 2023, 383, 122110 CrossRef CAS.
  272. A. Han, H. Zhang, J. Sun, G.-K. Chuah and S. Jaenicke, J. Water Process Eng., 2017, 17, 63–69 CrossRef.
  273. S. Rajendran, T. A. K. Priya, K. S. Khoo, T. K. A. Hoang, H.-S. Ng, H. S. H. Munawaroh, C. Karaman, Y. Orooji and P. L. Show, Chemosphere, 2022, 287, 132369 CrossRef CAS PubMed.
  274. A. Deepa, A. Mastan, V. Buddolla, Y. A. Kumar, B. A. Lakshmi and Y.-J. Kim, Int. Biodeterior. Biodegrad., 2025, 196, 105951 CrossRef CAS.
  275. H. Deng, Q. Hu, P. Zhu, A. Sun and S. Yang, Alexandria Eng. J., 2024, 105, 292–299 CrossRef.
  276. R. Khanam, S. A. Al Ashik, U. Suriea and S. Mahmud, Heliyon, 2024, 10, e27821 CrossRef CAS PubMed.
  277. M. T. Hamed, B. H. Elwakil, M. Hagar, D. A. Ghareeb and Z. A. Olama, Sci. Afr., 2025, 28, e02642 CAS.
  278. A. Bhunia, D. Lahiri, M. Nag, V. Upadhye and S. Pandit, Biocatal. Agric. Biotechnol., 2022, 43, 102397 CrossRef CAS.
  279. H. Feng, B. Wang, M. Wang, D. Ye, M. Wang, X. Sun, Y. Duan, D. Li, X. Zhang and Z. Zhu, Environ. Pollut., 2024, 362, 124979 CrossRef CAS PubMed.
  280. K. R. Krishna and L. Philip, J. Hazard. Mater., 2005, 121, 109–117 CrossRef CAS PubMed.
  281. A. Hedayatkhah, M. S. Cretoiu, G. Emtiazi, L. J. Stal and H. Bolhuis, J. Environ. Manage., 2018, 227, 313–320 CrossRef CAS PubMed.
  282. A. Ganguly, S. Nag, T. K. Bhowmick and K. Gayen, Algal Res., 2024, 82, 103635 CrossRef.
  283. R. Jobby, P. Jha, A. K. Yadav and N. Desai, Chemosphere, 2018, 207, 255–266 CrossRef CAS PubMed.
  284. H. A. Maitlo, K. H. Kim, V. Kumar, S. Kim and J. W. Park, Environ. Int., 2019, 130, 104748 CrossRef CAS PubMed.
  285. A. Azimi, A. Azari, M. Rezakazemi and M. Ansarpour, ChemBioEng Rev., 2017, 4, 37–59 CrossRef.
  286. A. Agrawal, V. Kumar and B. D. Pandey, Miner. Process. Extr. Metall. Rev., 2006, 27, 99–130 CrossRef CAS.
  287. R. Oral, S. Meriç, E. De Nicola, D. Petruzzelli, C. Della Rocca and G. Pagano, Desalination, 2007, 211, 48–57 CrossRef CAS.
  288. S. Rajoria, M. Vashishtha and V. K. Sangal, Environ. Sci. Pollut. Res., 2022, 29, 72196–72246 CrossRef CAS PubMed.
  289. B. Chattopadhyay, R. Gupta, A. Chatterjee and S. Mukhopadhyay, J. Am. Leather Chem. Assoc., 1999, 94, 337–346 CAS.
  290. S. R. Anand, R. Aggarwal, D. Saini, A. K. Sonker, N. Chauhan and S. K. Sonkar, Sol. Energy, 2019, 193, 774–781 CrossRef CAS.
  291. P. L. Care, R. G. McLaren and J. A. Adams, Water, Air, Soil Pollut., 1996, 87, 189–203 CrossRef.
  292. F. T. Angerasa, M. A. Kalifa, A. L. Jembere and M. B. Genet, S. Afr. J. Chem. Eng., 2021, 38, 90–103 Search PubMed.
  293. T. A. Kurniawan, M. E. T. Sillanpää and M. Sillanpää, Crit. Rev. Environ. Sci. Technol., 2012, 42, 1233–1295 CrossRef CAS.
  294. R. Chen, T. Sheehan, J. L. Ng, M. Brucks and X. Su, Environ. Sci.: Water Res. Technol., 2020, 6, 258–282 RSC.
  295. N. AlSawaftah, W. Abuwatfa, N. Darwish and G. Husseini, Water, 2021, 13 Search PubMed.
  296. K. Sarayu and S. Sandhya, Appl. Biochem. Biotechnol., 2012, 167, 645–661 CrossRef CAS PubMed.
  297. X. Yu, N. Jiang, Y. Yang, H. Liu, X. Gao and L. Cheng, Ecotoxicol. Environ. Saf., 2023, 263, 115305 CrossRef CAS PubMed.
  298. B. Chattopadhyay, R. Gupta, A. Chatterjee and S. Mukhopadhyay, J. Am. Leather Chem. Assoc., 1999, 94, 337–346 CAS.
  299. S. Sharma, S. Tiwari, A. Hasan, V. Saxena and L. M. Pandey, 3 Biotech, 2018, 8, 216 CrossRef PubMed.
  300. D. Mohan and C. U. Pittman, J. Hazard. Mater., 2006, 137, 762–811 CrossRef CAS PubMed.
  301. L. Liu, W. Li, W. Song and M. Guo, Sci. Total Environ., 2018, 633, 206–219 CrossRef CAS PubMed.
  302. K. Plessl, A. Russ and D. Vollprecht, Int. J. Environ. Sci. Technol., 2023, 20, 6913–6928 CrossRef CAS.
  303. Y. Wang, D. O'Connor, Z. Shen, I. M. C. Lo, D. C. W. Tsang, S. Pehkonen, S. Pu and D. Hou, J. Cleaner Prod., 2019, 226, 540–549 CrossRef CAS.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.